JP2014105167A - Cosmetic - Google Patents
Cosmetic Download PDFInfo
- Publication number
- JP2014105167A JP2014105167A JP2012257782A JP2012257782A JP2014105167A JP 2014105167 A JP2014105167 A JP 2014105167A JP 2012257782 A JP2012257782 A JP 2012257782A JP 2012257782 A JP2012257782 A JP 2012257782A JP 2014105167 A JP2014105167 A JP 2014105167A
- Authority
- JP
- Japan
- Prior art keywords
- plant
- acid
- skin
- extract
- rice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 30
- 240000007594 Oryza sativa Species 0.000 claims abstract description 57
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 57
- 239000000284 extract Substances 0.000 claims abstract description 57
- 241000196324 Embryophyta Species 0.000 claims abstract description 55
- 235000009566 rice Nutrition 0.000 claims abstract description 55
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 22
- 230000002087 whitening effect Effects 0.000 claims abstract description 15
- 241000219198 Brassica Species 0.000 claims abstract description 11
- 235000005807 Nelumbo Nutrition 0.000 claims abstract description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 17
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 240000005979 Hordeum vulgare Species 0.000 claims description 14
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 14
- 239000003963 antioxidant agent Substances 0.000 claims description 8
- 239000012190 activator Substances 0.000 claims description 6
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 6
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 230000017531 blood circulation Effects 0.000 claims description 5
- 239000003906 humectant Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 abstract description 29
- 238000000855 fermentation Methods 0.000 abstract description 25
- 230000004151 fermentation Effects 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 18
- 206010014970 Ephelides Diseases 0.000 abstract description 7
- 208000003351 Melanosis Diseases 0.000 abstract description 7
- 230000009759 skin aging Effects 0.000 abstract description 5
- 230000037303 wrinkles Effects 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 3
- 230000001766 physiological effect Effects 0.000 abstract description 3
- 241000894007 species Species 0.000 abstract description 3
- 235000011331 Brassica Nutrition 0.000 abstract description 2
- 241000209477 Nymphaeaceae Species 0.000 abstract description 2
- 241000219193 Brassicaceae Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract 1
- 206010040880 Skin irritation Diseases 0.000 abstract 1
- 239000000413 hydrolysate Substances 0.000 abstract 1
- 239000005445 natural material Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000007665 sagging Methods 0.000 abstract 1
- 230000036556 skin irritation Effects 0.000 abstract 1
- 231100000475 skin irritation Toxicity 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 105
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 50
- 102000004190 Enzymes Human genes 0.000 description 46
- 229940088598 enzyme Drugs 0.000 description 46
- 108090000790 Enzymes Proteins 0.000 description 45
- 238000000605 extraction Methods 0.000 description 44
- 238000009472 formulation Methods 0.000 description 42
- -1 for example Proteins 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 30
- 239000004310 lactic acid Substances 0.000 description 25
- 235000014655 lactic acid Nutrition 0.000 description 25
- 239000000523 sample Substances 0.000 description 25
- 239000002904 solvent Substances 0.000 description 25
- 241000894006 Bacteria Species 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 21
- 239000006210 lotion Substances 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 16
- 239000000725 suspension Substances 0.000 description 16
- 238000011282 treatment Methods 0.000 description 16
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 14
- 239000008213 purified water Substances 0.000 description 14
- 235000002597 Solanum melongena Nutrition 0.000 description 12
- 244000061458 Solanum melongena Species 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 230000007062 hydrolysis Effects 0.000 description 12
- 238000006460 hydrolysis reaction Methods 0.000 description 12
- 108091005804 Peptidases Proteins 0.000 description 11
- 102000035195 Peptidases Human genes 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 210000002950 fibroblast Anatomy 0.000 description 10
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 10
- 235000011511 Diospyros Nutrition 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000004365 Protease Substances 0.000 description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 9
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 9
- 229960004705 kojic acid Drugs 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 235000019834 papain Nutrition 0.000 description 9
- 241000723267 Diospyros Species 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 239000000686 essence Substances 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 229940058015 1,3-butylene glycol Drugs 0.000 description 7
- 244000025254 Cannabis sativa Species 0.000 description 7
- 235000013162 Cocos nucifera Nutrition 0.000 description 7
- 244000060011 Cocos nucifera Species 0.000 description 7
- 108090000526 Papain Proteins 0.000 description 7
- 241000593344 Rhizopus microsporus Species 0.000 description 7
- 102000003425 Tyrosinase Human genes 0.000 description 7
- 108060008724 Tyrosinase Proteins 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 229960005070 ascorbic acid Drugs 0.000 description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 235000015165 citric acid Nutrition 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 229940055729 papain Drugs 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 244000000626 Daucus carota Species 0.000 description 6
- 235000002767 Daucus carota Nutrition 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 6
- 102100022624 Glucoamylase Human genes 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 6
- 240000006439 Aspergillus oryzae Species 0.000 description 5
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 241000194033 Enterococcus Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 229960000271 arbutin Drugs 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 5
- 229960000401 tranexamic acid Drugs 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 4
- 241000195628 Chlorophyta Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 4
- 240000006024 Lactobacillus plantarum Species 0.000 description 4
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 4
- 235000006484 Paeonia officinalis Nutrition 0.000 description 4
- 241000199919 Phaeophyceae Species 0.000 description 4
- 241000206572 Rhodophyta Species 0.000 description 4
- 241000235006 Torulaspora Species 0.000 description 4
- 241000235017 Zygosaccharomyces Species 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 230000003625 amylolytic effect Effects 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 239000007844 bleaching agent Substances 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 229940105039 coconut extract Drugs 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 229940072205 lactobacillus plantarum Drugs 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 230000037393 skin firmness Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- OYAQUBKYAKSHOA-UHFFFAOYSA-N 2-(2-hydroxy-5-propylphenyl)-4-propylphenol Chemical compound CCCC1=CC=C(O)C(C=2C(=CC=C(CCC)C=2)O)=C1 OYAQUBKYAKSHOA-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 3
- 244000274847 Betula papyrifera Species 0.000 description 3
- 235000009113 Betula papyrifera Nutrition 0.000 description 3
- 235000009109 Betula pendula Nutrition 0.000 description 3
- 235000010928 Betula populifolia Nutrition 0.000 description 3
- 235000002992 Betula pubescens Nutrition 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- 240000003538 Chamaemelum nobile Species 0.000 description 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- 241000194036 Lactococcus Species 0.000 description 3
- 241000192132 Leuconostoc Species 0.000 description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 241000736199 Paeonia Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 241000235070 Saccharomyces Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 241000207194 Vagococcus Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229940106157 cellulase Drugs 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000002366 lipolytic effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- 244000021317 Annona cherimola Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193818 Atopobium Species 0.000 description 2
- 235000006463 Brassica alba Nutrition 0.000 description 2
- 244000178993 Brassica juncea Species 0.000 description 2
- 235000011332 Brassica juncea Nutrition 0.000 description 2
- 235000014700 Brassica juncea var napiformis Nutrition 0.000 description 2
- 235000011291 Brassica nigra Nutrition 0.000 description 2
- 244000180419 Brassica nigra Species 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 2
- 235000004936 Bromus mango Nutrition 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 241000206594 Carnobacterium Species 0.000 description 2
- 241000269333 Caudata Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 235000017048 Garcinia mangostana Nutrition 0.000 description 2
- 240000006053 Garcinia mangostana Species 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- 235000005206 Hibiscus Nutrition 0.000 description 2
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 2
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 241000234435 Lilium Species 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 235000014826 Mangifera indica Nutrition 0.000 description 2
- 240000007228 Mangifera indica Species 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 240000001307 Myosotis scorpioides Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000007189 Oryza longistaminata Nutrition 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 241000242583 Scyphozoa Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000009184 Spondias indica Nutrition 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 235000012547 cherimoya Nutrition 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical class O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 244000128879 sarson Species 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000013322 soy milk Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- QVSVMNXRLWSNGS-UHFFFAOYSA-N (3-fluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1 QVSVMNXRLWSNGS-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- LNJRMYPOKFOJBQ-UHFFFAOYSA-N 1-(4-tert-butyl-4-methoxycyclohexa-1,5-dien-1-yl)ethanone Chemical compound COC1(C(C)(C)C)CC=C(C(C)=O)C=C1 LNJRMYPOKFOJBQ-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- ATWGXJGRRXIETI-UHFFFAOYSA-N 2,5-diacetyloxybenzoic acid Chemical compound CC(=O)OC1=CC=C(OC(C)=O)C(C(O)=O)=C1 ATWGXJGRRXIETI-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GWHXAZLLZVWMNI-UHFFFAOYSA-N 2-acetyloxy-5-hydroxybenzoic acid Chemical compound CC(=O)OC1=CC=C(O)C=C1C(O)=O GWHXAZLLZVWMNI-UHFFFAOYSA-N 0.000 description 1
- UPHOTCBFZHQJEK-UHFFFAOYSA-N 2-hydroxy-5-propanoyloxybenzoic acid Chemical compound CCC(=O)OC1=CC=C(O)C(C(O)=O)=C1 UPHOTCBFZHQJEK-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- GXNGGBMNYUHZOZ-UHFFFAOYSA-N 4-(1-hydroxybutyl)phenol Chemical compound CCCC(O)C1=CC=C(O)C=C1 GXNGGBMNYUHZOZ-UHFFFAOYSA-N 0.000 description 1
- NYARJMRXCRSQPJ-UHFFFAOYSA-N 4-(3-methylbutyl)benzene-1,3-diol Chemical compound CC(C)CCC1=CC=C(O)C=C1O NYARJMRXCRSQPJ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- KTXUGZHJVRHQGP-UHFFFAOYSA-N 4-Hydroxy-1-(3-pyridinyl)-1-butanone Chemical compound OCCCC(=O)C1=CC=CN=C1 KTXUGZHJVRHQGP-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241001112078 Aspergillus usamii Species 0.000 description 1
- 241000223651 Aureobasidium Species 0.000 description 1
- 241000307611 Aureobasidium mansonii Species 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241001037822 Bacillus bacterium Species 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241001530515 Candida sake Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000206593 Carnobacterium divergens Species 0.000 description 1
- 241000206600 Carnobacterium maltaromaticum Species 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 108090001069 Chymopapain Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 241000194038 Lactococcus plantarum Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001468192 Leuconostoc citreum Species 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- 229930182636 Magnolignan Natural products 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000030999 Monascus pilosus Species 0.000 description 1
- 235000002322 Monascus purpureus Nutrition 0.000 description 1
- 244000113306 Monascus purpureus Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 244000265736 Nelumbo pentapetala Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241001527087 Panax vietnamensis Species 0.000 description 1
- 235000017726 Panax vietnamensis Nutrition 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000500340 Pediococcus damnosus Species 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000006328 Rhizopus azygosporus Species 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 1
- 241000877399 Saccharomyces chevalieri Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241000396377 Tranes Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 241000207192 Vagococcus salmoninarum Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000186675 Weissella confusa Species 0.000 description 1
- 241000186837 Weissella kandleri Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 235000001329 Ziziphus joazeiro Nutrition 0.000 description 1
- 244000158786 Ziziphus joazeiro Species 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- FWFKWYODLSFYLE-UHFFFAOYSA-J [Na+].[Na+].[Na+].[Na+].CCO.[O-]P(=O)OP([O-])=O.[O-]P(=O)OP([O-])=O Chemical compound [Na+].[Na+].[Na+].[Na+].CCO.[O-]P(=O)OP([O-])=O.[O-]P(=O)OP([O-])=O FWFKWYODLSFYLE-UHFFFAOYSA-J 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 229940033280 alpha-arbutin Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000020054 awamori Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229960002976 chymopapain Drugs 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical group CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229940083256 peripheral vasodilators nicotinic acid and derivative Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- LRUISGPJGHTCRR-LEJBHHMKSA-M sodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] sulfate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(OS([O-])(=O)=O)=C1O LRUISGPJGHTCRR-LEJBHHMKSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 235000013548 tempeh Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Abstract
Description
本発明は、すぐれた美肌化、美白作用を有し、安全性の高い化粧料に関するものである。 The present invention relates to cosmetics having excellent skin beautification and whitening effects and high safety.
皮膚の老化は、加齢に伴う細胞増殖・分化の不活化、ホルモン分泌の低下、細胞外マトリックス成分の量的低下などの内的要因と、太陽光(紫外線)に誘発される活性酸素による細胞・組織の損傷、又は炎症などの外的要因とが複雑に絡み合って生ずる現象である。 Skin aging is caused by internal factors such as inactivation of cell growth / differentiation associated with aging, decreased hormone secretion, quantitative decrease of extracellular matrix components, and cells caused by active oxygen induced by sunlight (ultraviolet rays). -Phenomenon caused by complex intertwining with external factors such as tissue damage or inflammation.
皮膚老化の外的要因である活性酸素は皮膚細胞に直接傷害を及ぼすばかりでなく、細胞外マトリックス成分のコラーゲンを変性又は架橋させてシワの形成や皮膚の弾力性の低下をもたらし、さらにはメラニン色素の異常沈着を誘発してシミ、ソバカスを生じさせるなど、肌に様々なダメージを与える。 Reactive oxygen, an external factor of skin aging, not only directly damages skin cells, but also denatures or crosslinks the collagen of the extracellular matrix component, resulting in wrinkle formation and reduced skin elasticity. It causes various damages to the skin, such as causing abnormal pigmentation and causing spots and freckles.
この皮膚の老化を防ぎ、皮膚を健全、かつ、若々しい状態に保持するため、従来、種々の活性成分の使用が提案され、それら美肌化及び美白成分を配合した化粧品が上市されている。例えば、ビタミンC、ビタミンE、スーパーオキシドジスムターゼ(Superoxide dismutase;以下SODと略記)、カタラーゼなどの抗酸化剤;グリチルリチン酸などの抗炎症剤;各種紫外線吸収剤;α−ヒドロキシカルボン酸、胎盤抽出液、γ−アミノ−β−ヒドロキシ酪酸などの細胞賦活成分;コラーゲン、エラスチン、ヒアルロン酸などの細胞外マトリックス成分;尿素などの保湿剤がそれである。また、皮膚のシミ、ソバカス等の色素沈着の発生を抑制する物質としては、アルブチン、コウジ酸などが知られており、美白剤の有効成分として広く使用されている。 In order to prevent this skin aging and keep the skin healthy and youthful, the use of various active ingredients has been proposed in the past, and cosmetics containing these skin-beautifying and whitening ingredients have been put on the market. For example, vitamin C, vitamin E, superoxide dismutase (hereinafter abbreviated as SOD), an antioxidant such as catalase; an anti-inflammatory agent such as glycyrrhizic acid; various ultraviolet absorbers; α-hydroxycarboxylic acid, placenta extract Cell activation components such as γ-amino-β-hydroxybutyric acid; extracellular matrix components such as collagen, elastin and hyaluronic acid; and humectants such as urea. Further, arbutin, kojic acid, and the like are known as substances that suppress the occurrence of pigmentation such as skin spots and buckwheat, and are widely used as active ingredients of whitening agents.
しかし、それら従来の美肌化剤及び美白剤には、皮膚などに対する安全性、また、実際に皮膚に適用した際の有効性の観点で問題が存在する。また、種々の天然成分由来の美肌化剤及び美白剤も提案されているが(特許文献1、2)、それらの剤の美肌化及び美白効果は、化粧料配合原料として見た場合に、皮膚などに対する安全性、また、実際に皮膚に適用した際の有効性の観点で問題が存在する。従って、かかる点が改善された化粧料配合成分を含む化粧料が求められている。
本発明者らは、かかる従来技術の問題点に鑑みて、皮膚安全性の観点から天然物由来の新たな美肌化及び美白成分を見出すべく鋭意研究を行った。その結果、米、アブラナ科ブラシカ属の植物、及びスイレン科ハス属の植物、及びハトムギうちの3種以上の植物から得られる成分を併用することで、すぐれた美肌化及び美白効果を奏し、かつ、皮膚安全性にすぐれた化粧料の提供が可能になることを見出し、本発明を完成するに至った。 In view of the problems of the prior art, the present inventors have intensively studied to find new skin-beautifying and whitening ingredients derived from natural products from the viewpoint of skin safety. As a result, by using together the ingredients obtained from three or more kinds of plants of rice, Brassicaceae Brassica, water lily family Lotus, and pearl barley, there are excellent skin beautification and whitening effects, and The present inventors have found that it is possible to provide cosmetics with excellent skin safety, and have completed the present invention.
本発明は、米、アブラナ科ブラシカ属(Brassica)の植物、スイレン科(Nympaeaceae)ハス属(Nelumbo)の植物、及びハトムギのうちの3種以上の植物の成分を含む化粧料であって、上記植物の成分は当該植物の抽出物又は当該抽出物の加水分解物、或いは当該植物の発酵物であることを特徴とする。
又、本発明は、さらに、美白剤、保湿剤、細胞賦活剤、抗炎症剤、抗酸化剤、及び血行促進剤のいずれか一種以上を含むことを特徴とする化粧料である。
なお、本発明に於いて、化粧料なる文言は、所謂化粧料のほかに医薬部外品をも含む広義の意味で用いる。
The present invention is a cosmetic comprising three or more plant components of rice, Brassica plant, Nympaeaceae lotus (Nelumbo) plant, and pearl barley, The plant component is an extract of the plant, a hydrolyzate of the extract, or a fermented product of the plant.
In addition, the present invention is a cosmetic characterized by further including any one or more of a whitening agent, a moisturizing agent, a cell activator, an anti-inflammatory agent, an antioxidant and a blood circulation promoter.
In the present invention, the term cosmetic is used in a broad sense including so-called cosmetics and quasi-drugs.
本発明は、米、アブラナ科ブラシカ属の植物、スイレン科ハス属の植物、及びハトムギのうちの3種以上の植物の成分を含む化粧料であって、上記植物の成分は当該植物の抽出物又は当該抽出物の加水分解物、或いは当該植物の発酵物であることから、これら植物の成分が有するチロシナーゼ活性抑制作用、線維芽細胞賦活作用などの効果により、すぐれた美肌及び美白効果を発揮する化粧料を提供することができる。 The present invention is a cosmetic comprising three or more kinds of plants among rice, Brassicaceae Brassica plant, Lilyaceae lotus plant, and pearl barley, wherein the plant component is an extract of the plant Or, since it is a hydrolyzate of the extract or a fermented product of the plant, it exhibits excellent skin and whitening effects due to the tyrosinase activity inhibitory action, fibroblast activation action, etc. possessed by these plant components. Cosmetics can be provided.
本発明に於いて用いる米には特に制限はなく、玄米、精白米、加工米、有色素米(黒米、紫米、赤米など)などのいずれもが使用可能であるが、好適には精白米もしくは加工米が使用される。米の種類としては、粳米、もち米等のいずれを使用してもよい。また、加工米としては、抗アレルギー米、低蛋白米(例えば低グリテリン米)、強化米(例えばγ−アミノ酪酸米)などが挙げられる。又、玄米に含まれる白糠及び/又は赤糠の使用も可能である。 The rice used in the present invention is not particularly limited, and any of brown rice, polished rice, processed rice, pigmented rice (black rice, purple rice, red rice, etc.) can be used. White rice or processed rice is used. As the type of rice, either sticky rice or glutinous rice may be used. In addition, examples of processed rice include antiallergic rice, low protein rice (for example, low glycerin rice), and fortified rice (for example, γ-aminobutyric acid rice). Moreover, the use of white rice and / or red rice contained in brown rice is also possible.
又、本発明に於いてアブラナ科ブラシカ属の植物としては、例えば白芥(Brassica alba)、黄芥(Brassica juncea)、黒芥(Brassica nigra)、アブラナ(Brassica ropa)などを挙げることができる。それらブラシカ属植物のうちでも、白芥(Brassica alba)、黄芥(Brassica juncea)或いは黒芥(Brassica nigra)が好ましい。それら植物の全草、種子、葉、茎、根、花のいずれの部位の使用も可能であるが、それらの中でも全草又は種子(即ち、白芥子、黄芥子又は黒芥子)の使用が好ましい。 In the present invention, examples of the Brassicaceae Brassica plant include, for example, Brassica alba, Brassica juncea, Brassica nigra, Brassica ropa, and the like. Among these Brassica plants, white cocoon (Brassica alba), yellow cocoon (Brassica juncea) or black cocoon (Brassica nigra) is preferable. The whole plant, seeds, leaves, stems, roots and flowers of these plants can be used, but among them, the use of whole plants or seeds (ie, white coconut, yellow coconut or black coconut) is preferred. .
本発明で用いるスイレン科ハス属の植物としては、例えばハス(Nelumbo nucifera
Gaertner)或いはアメリカキバス(Nelumbo Lutea Pers.)などが挙げられるが、それらのうちでも、ハス(Nelumbo nucifera Gaertner)の使用が好ましい。それらの植物の全草、葉、花、雄しべ、雌しべ、茎、根茎、種子(子実)、胚芽などのいずれの部分を使用してもよいが、種子の使用が好ましい。
Examples of the plant belonging to the genus Lotusaceae used in the present invention include lotus (Nelumbo nucifera).
Gaertner) or American kibas (Nelumbo Lutea Pers.) Can be mentioned. Among them, the use of lotus (Nelumbo nucifera Gaertner) is preferable. Any part of these plants such as whole grass, leaves, flowers, stamens, pistils, stems, rhizomes, seeds (grains) and germs may be used, but the use of seeds is preferred.
本発明で用いるハトムギは、イネ科ジュズダマ属の植物であって、薬用や食用に幅広く用いられているものである。本発明に於いては、ハトムギの全草、葉、花、茎、根、種子などのいずれの部分を使用してもよいが、種子の使用が好ましい。 The pearl barley used in the present invention is a plant belonging to the genus Giusedama, and is widely used for medicinal purposes and food. In the present invention, any part of pearl barley, leaves, flowers, stems, roots, seeds and the like may be used, but the use of seeds is preferred.
以上の植物を用いて抽出物を調製する方法を以下に説明する。抽出物の調製は、それぞれの植物の抽出対象部位を、必要に応じて予め水洗い、乾燥し、又細切もしくは粉砕した上で、浸漬法、向流抽出法、超臨界抽出法などの常法によって抽出溶媒に接触させることで行うことができる。 A method for preparing an extract using the above plants will be described below. Preparation of the extract is carried out by conventional methods such as immersion method, countercurrent extraction method, supercritical extraction method, etc., after pre-washing the extraction target site of each plant as necessary, drying, chopping or grinding. By contacting with an extraction solvent.
抽出溶媒としては、水;メタノール、エタノール、プロパノールなどの低級アルコール類;エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなどの多価アルコール類;酢酸エチル、酢酸ブチル、プロピオン酸メチルなどのエステル類;アセトン、メチルエチルケトンなどのケトン類;エチルエーテル、イソプロピルエーテルなどのエーテル類;n−ヘキサン、トルエン、クロロホルムなどの炭化水素系溶媒などが挙げられ、それらは単独で又は二種以上混合して用いられる。 As an extraction solvent, water; lower alcohols such as methanol, ethanol, propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, glycerin; ethyl acetate, butyl acetate, methyl propionate, etc. Esters; Ketones such as acetone and methyl ethyl ketone; Ethers such as ethyl ether and isopropyl ether; Hydrocarbon solvents such as n-hexane, toluene and chloroform, and the like. These may be used alone or in combination of two or more. Used.
それら抽出溶媒のうちでも、抽出物に後述の加水分解処理を施す場合の当該処理工程への移行の容易性や化粧料への幅広い適用が可能であるという点からも、本発明においては水或いは水と低級アルコール類又は多価アルコール類との混合溶媒の使用が好ましい。混合溶媒を用いる場合は水に対する低級アルコールや多価アルコールの混合割合は、一般には70重量%以下、好ましくは50%重量以下である。 Among these extraction solvents, water or water is used in the present invention from the viewpoint of ease of transition to the treatment step when the extract is subjected to the hydrolysis treatment described below and wide application to cosmetics. The use of a mixed solvent of water and lower alcohols or polyhydric alcohols is preferred. When a mixed solvent is used, the mixing ratio of the lower alcohol or polyhydric alcohol to water is generally 70% by weight or less, preferably 50% by weight or less.
抽出物の調製に際して、そのpH、温度及時間に特に限定はないが、使用する植物の抽出対象部位により適宜選択することが好ましい。 In preparing the extract, the pH, temperature and time are not particularly limited, but it is preferable to select appropriately depending on the extraction target site of the plant to be used.
例えば、米の抽出物の調製に於いては、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤を用いて、pH7.5〜14、特にpH9〜12の範囲とすることが好ましい。この場合の抽出温度及び時間は、米の種類、粒度によっても異なるが、一般に4〜40℃で6時間〜7日間、好ましくは50〜60℃で12〜36時間であり、80℃で1〜12時間である。 For example, in the preparation of rice extract, it is preferable to use an alkaline adjuster such as sodium hydroxide, sodium carbonate, potassium hydroxide, etc., so that the pH is in the range of 7.5 to 14, particularly 9 to 12. The extraction temperature and time in this case vary depending on the type and particle size of the rice, but are generally 4 to 40 ° C. for 6 hours to 7 days, preferably 50 to 60 ° C. for 12 to 36 hours, and 80 ° C. for 1 to 1 hour. 12 hours.
又、本発明の抽出物の調製に際して、抽出対象部位として、アブラナ科ブラシカ属の例えば白芥、黒芥、又は黄芥の種子を用いる場合は、一般には3〜9の範囲とすることが好ましく、かかる意味で、必要ならば前記の抽出溶媒に、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤や、クエン酸、塩酸、リン酸、硫酸などの酸性調整剤等を添加し、目的とするpHとなるように調整してもよい。又抽出温度、抽出時間等の抽出条件は、用いる溶媒の種類やpH、或いは被抽出物の細切度、粒度等によっても異なるが、例えば水を抽出溶媒とする浸漬法の場合であれば、抽出温度は一般に1〜90℃、好ましくは20〜60℃の範囲であり、又抽出時間は、例えば、室温の場合で0.5〜72時間の範囲、好ましくは1〜24時間の範囲である。 When preparing the extract of the present invention, when using, for example, white birch, black cocoon, or jaundice seeds belonging to the Brassicaceae Brassica genus as the extraction target site, it is generally preferably in the range of 3-9. In this sense, if necessary, an alkaline adjusting agent such as sodium hydroxide, sodium carbonate or potassium hydroxide, or an acidic adjusting agent such as citric acid, hydrochloric acid, phosphoric acid or sulfuric acid is added to the extraction solvent. You may adjust so that it may become the target pH. Extraction conditions such as extraction temperature and extraction time vary depending on the type and pH of the solvent to be used, or the shredding degree and particle size of the extract, but for example, in the case of the immersion method using water as the extraction solvent, The extraction temperature is generally in the range of 1 to 90 ° C., preferably 20 to 60 ° C., and the extraction time is, for example, in the case of room temperature in the range of 0.5 to 72 hours, preferably in the range of 1 to 24 hours. .
又、本発明の抽出物の調製に際して、抽出対象部位として、例えば、スイレン科ハス属植物の種子を用いる場合は、一般には4〜8の範囲とすることが好ましく、かかる意味で、必要ならば前記の抽出溶媒に、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤や、クエン酸、塩酸、リン酸、硫酸などの酸性調整剤等を添加し、目的とするpHとなるように調整してもよい。又抽出温度、抽出時間等の抽出条件は、用いる溶媒の種類やpH、或いは被抽出物の細切度、粒度等によっても異なるが、例えば水を抽出溶媒とする浸漬法の場合であれば、抽出温度は一般に1〜90℃、好ましくは40〜85℃の範囲であり、又抽出時間は、例えば、室温で0.5〜72時間の範囲であり、又40〜80℃で1〜12時間の範囲である。 Moreover, when preparing the extract of the present invention, for example, when using seeds of the genus Lotusaceae as the extraction target site, it is generally preferably in the range of 4 to 8, and in this sense, if necessary Add alkaline adjusters such as sodium hydroxide, sodium carbonate, potassium hydroxide, and acidic adjusters such as citric acid, hydrochloric acid, phosphoric acid, sulfuric acid, etc. to the extraction solvent so as to achieve the desired pH. You may adjust. Extraction conditions such as extraction temperature and extraction time vary depending on the type and pH of the solvent to be used, or the shredding degree and particle size of the extract, but for example, in the case of the immersion method using water as the extraction solvent, The extraction temperature is generally in the range of 1 to 90 ° C., preferably 40 to 85 ° C., and the extraction time is, for example, in the range of 0.5 to 72 hours at room temperature, and 1 to 12 hours at 40 to 80 ° C. Range.
又、本発明の抽出物の調製に際して、抽出対象部位として、例えば、スイレン科ハス属植物の種子を用いる場合は、一般には4〜8の範囲とすることが好ましく、かかる意味で、必要ならば前記の抽出溶媒に、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤や、クエン酸、塩酸、リン酸、硫酸などの酸性調整剤等を添加し、目的とするpHとなるように調整してもよい。又抽出温度、抽出時間等の抽出条件は、用いる溶媒の種類やpH、或いは被抽出物の細切度、粒度等によっても異なるが、例えば水を抽出溶媒とする浸漬法の場合であれば、抽出温度は一般に1〜90℃、好ましくは40〜85℃の範囲であり、又抽出時間は、室温で0.5〜72時間の範囲、40〜80度で1〜12時間の範囲である。 Moreover, when preparing the extract of the present invention, for example, when using seeds of the genus Lotusaceae as the extraction target site, it is generally preferably in the range of 4 to 8, and in this sense, if necessary Add alkaline adjusters such as sodium hydroxide, sodium carbonate, potassium hydroxide, and acidic adjusters such as citric acid, hydrochloric acid, phosphoric acid, sulfuric acid, etc. to the extraction solvent so as to achieve the desired pH. You may adjust. Extraction conditions such as extraction temperature and extraction time vary depending on the type and pH of the solvent to be used, or the shredding degree and particle size of the extract, but for example, in the case of the immersion method using water as the extraction solvent, The extraction temperature is generally in the range of 1 to 90 ° C, preferably 40 to 85 ° C, and the extraction time is in the range of 0.5 to 72 hours at room temperature and in the range of 1 to 12 hours at 40 to 80 degrees.
又、本発明の抽出物の調製に際して、抽出対象部位として、例えば、ハトムギの種子を用いる場合は、一般には4〜8の範囲とすることが好ましく、かかる意味で、必要ならば前記の抽出溶媒に、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤や、クエン酸、塩酸、リン酸、硫酸などの酸性調整剤等を添加し、目的とするpHとなるように調整してもよい。又抽出温度、抽出時間等の抽出条件は、用いる溶媒の種類やpH、或いは被抽出物の細切度、粒度等によっても異なるが、例えば水を抽出溶媒とする浸漬法の場合であれば、抽出温度は一般に1〜90℃、好ましくは40〜85℃の範囲であり、又抽出時間は、室温で0.5〜72時間の範囲、40〜80度で1〜12時間の範囲である。 In the preparation of the extract of the present invention, for example, when pearl seeds are used as the extraction target site, it is generally preferably in the range of 4 to 8, and in this sense, the extraction solvent described above is used if necessary. In addition, an alkaline adjusting agent such as sodium hydroxide, sodium carbonate, potassium hydroxide or an acidic adjusting agent such as citric acid, hydrochloric acid, phosphoric acid, sulfuric acid, etc. may be added to adjust to the desired pH. Good. Extraction conditions such as extraction temperature and extraction time vary depending on the type and pH of the solvent to be used, or the shredding degree and particle size of the extract, but for example, in the case of the immersion method using water as the extraction solvent, The extraction temperature is generally in the range of 1 to 90 ° C, preferably 40 to 85 ° C, and the extraction time is in the range of 0.5 to 72 hours at room temperature and in the range of 1 to 12 hours at 40 to 80 degrees.
本発明に於いては、上記抽出処理により得られる抽出物を、抽出前又は抽出後、或いは抽出と並行して、加水分解処理を行ってもよい。加水分解処理としては、酸、アルカリ、酵素などによる方法が挙げられるが、酵素を用いた加水分解処理が好ましい。酵素を用いて加水分解を行う場合であって、抽出物溶液の調製に、水或いは水と親水性溶媒との混合溶媒以外の溶媒を用いたときには、抽出物溶液から一旦抽出溶媒を除去し、ここに得られる抽出物を、水或いは水と親水性溶媒との混合溶媒に再溶解した上酵素分解処理に供するようにする。 In the present invention, the extract obtained by the extraction process may be subjected to a hydrolysis process before or after extraction or in parallel with the extraction. Examples of the hydrolysis treatment include a method using an acid, an alkali, an enzyme, and the like, but a hydrolysis treatment using an enzyme is preferable. In the case where hydrolysis is performed using an enzyme, and when a solvent other than water or a mixed solvent of water and a hydrophilic solvent is used for preparing the extract solution, the extract solvent is once removed from the extract solution, The extract obtained here is redissolved in water or a mixed solvent of water and a hydrophilic solvent and then subjected to an enzymatic decomposition treatment.
加水分解処理に用いる酵素としては、蛋白分解酵素、澱粉分解酵素、繊維素分解酵素、及び脂肪分解酵素が挙げられる。これらの酵素は植物種に応じて、それぞれの単独で使用しても複数の酵素を組み合わせて使用してもよい。 Examples of enzymes used for the hydrolysis treatment include proteolytic enzymes, starch degrading enzymes, fibrinolytic enzymes, and lipolytic enzymes. These enzymes may be used alone or in combination with a plurality of enzymes depending on the plant species.
蛋白分解酵素としては、例えばアクチナーゼなどのアクチナーゼ類、ペプシンなどのペプシン類、トリプシン、キモトリプシンなどのトリプシン類、パパイン、キモパパインなどのパパイン類、グリシルグリシンペプチダーゼ、カルボキシペプチダーゼ、アミノペプチダーゼなどのペプチダーゼ類、ブロメライン、微生物由来の複合蛋白分解酵素[例えば、ニューラーゼ(天野エンザイム株式会社製)]などが挙げられる。蛋白分解酵素を使用する場合、上述した酵素のいずれかを単独で用いても、複数を組み合わせても良い。又、澱粉分解酵素としては、例えば、α−アミラーゼ、β−アミラーゼ、グルコアミラーゼ、β−ガラクトシダーゼなどを用いることができる。澱粉分解酵素を使用する場合、上述した酵素のいずれかを単独で用いても、複数を組み合わせても良い。又、繊維素分解酵素としては、例えば、セルラーゼ、ヘミセルラーゼ、ペクチナーゼなどが挙げられる。繊維素分解酵素を使用する場合、上述した酵素のいずれかを単独で用いても、複数を組み合わせても良い。又、脂肪分解酵素としては、例えば、リパーゼが挙げられる。なお、酵素による加水分解処理を行う場合に、上記各酵素群から選ばれる1種以上の酵素を複数組み合わせて使用しても良い。 Examples of proteolytic enzymes include actinases such as actinase, pepsins such as pepsin, trypsins such as trypsin and chymotrypsin, papains such as papain and chymopapain, peptidases such as glycylglycine peptidase, carboxypeptidase and aminopeptidase, Bromelain, microorganism-derived complex proteolytic enzyme [for example, neurase (manufactured by Amano Enzyme Co., Ltd.)] and the like. When using a proteolytic enzyme, any of the above-described enzymes may be used alone or in combination. Further, as the amylolytic enzyme, for example, α-amylase, β-amylase, glucoamylase, β-galactosidase and the like can be used. When using a amylolytic enzyme, any of the above-described enzymes may be used alone, or a plurality of them may be combined. Examples of the fibrinolytic enzyme include cellulase, hemicellulase, and pectinase. When a fibrinolytic enzyme is used, any of the above-described enzymes may be used alone, or a plurality may be combined. Examples of the lipolytic enzyme include lipase. In addition, when performing the hydrolysis process with an enzyme, you may use combining 1 or more types of 1 or more types of enzymes chosen from said each enzyme group.
酵素を用いた加水分解処理は、上述した植物の抽出物溶液に上記の酵素の1種又は2種以上を添加し、用いた酵素の至適pH及び至適温度付近の条件下で酵素反応させることによって実施される。2種以上の酵素を組み合わせ用いる場合は、用いる酵素の特性に応じて、2種以上の酵素を同時に作用させてもよく、又反応条件を変えもしくは変えずして順次作用させるようにしてもよい。酵素の使用量は、植物抽出物溶液の固形分100重量部に対して、1種の酵素につき0.001〜50重量部の範囲とするのがよく、より好ましくは0.1〜10重量部の範囲である。又、酵素処理の時間は、用いる酵素の種類等によっても異なるが、一般には0.5〜24時間の範囲であり、好ましくは1〜6時間の範囲である。なお、上記植物を加水分解する場合は、蛋白分解酵素の1種又は2種以上、或いは蛋白分解酵素の1種又は2種以上にさらに澱粉分解酵素及び/又は繊維素分解酵素を組み合わせるのが好ましい。さらに、蛋白分解酵素としては、パパイン類、ブロメライン及び/又はアクチナーゼ類の使用が好ましい。 In the hydrolysis treatment using an enzyme, one or more of the above enzymes are added to the above-described plant extract solution, and the enzyme is reacted under conditions near the optimum pH and temperature of the enzyme used. To be implemented. When two or more kinds of enzymes are used in combination, two or more kinds of enzymes may be allowed to act simultaneously according to the characteristics of the enzyme used, or may be allowed to act sequentially without changing or changing the reaction conditions. . The amount of the enzyme used is preferably in the range of 0.001 to 50 parts by weight, more preferably 0.1 to 10 parts by weight per one enzyme with respect to 100 parts by weight of the solid content of the plant extract solution. Range. The enzyme treatment time varies depending on the type of enzyme used and the like, but is generally in the range of 0.5 to 24 hours, preferably in the range of 1 to 6 hours. In addition, when hydrolyzing the said plant, it is preferable to combine amylolytic enzyme and / or a fibrinolytic enzyme with 1 type, 2 or more types of proteolytic enzymes, or 1 type or 2 types or more of proteolytic enzymes. . Furthermore, it is preferable to use papains, bromelain and / or actinases as proteolytic enzymes.
以上の酵素を用いて加水分解処理終了後、酵素処理液を例えば80℃以上に加熱する方法など適宜の方法を用いて酵素を失活させ、酵素処理分解物溶液を得る。 After completion of the hydrolysis treatment using the above enzyme, the enzyme is deactivated by using an appropriate method such as a method of heating the enzyme treatment liquid to, for example, 80 ° C. or higher to obtain an enzyme-treated decomposition product solution.
上述のように調製した抽出物又は加水分解処理物は、一般にはpHを4〜8に調製した上で、これをそのままの状態で化粧料配合剤として使用しても良く、又減圧濃縮等により所望の濃度として使用しても良い。また、抽出物はスプレードライ法等の常法により乾燥物としても良い。 In general, the extract or the hydrolyzed product prepared as described above may be used as a cosmetic compounding agent as it is after adjusting the pH to 4 to 8, or by vacuum concentration or the like. It may be used as a desired concentration. In addition, the extract may be dried by a conventional method such as spray drying.
又、本発明に於いては、上記植物の発酵物を用いてもよい。発酵に用いる微生物としては、乳酸菌、麹菌、納豆菌、テンペ菌、酵母等が挙げられ、一般にはそれら各菌種のいずれかから選ばれた一種又は二種以上を用いるが、場合によっては、又相互に発酵の妨げとならない限り、別の菌種に属するもの同士を組み合せ用いるようにしてもよい。 In the present invention, a fermented product of the above plant may be used. Examples of microorganisms used for fermentation include lactic acid bacteria, koji molds, natto bacteria, tempeh bacteria, yeasts, etc., and generally one or more selected from any of these bacterial species are used. As long as they do not interfere with each other, they may be used in combination with those belonging to different bacterial species.
ここで乳酸菌としては、例えばラクトバシルス プランタラム(Lactobacillus plantarum)、ラクトバシルス
ブレビス(L. brevis)、ラクトバシルス カゼイ(L. casei)等のラクトバシルス(Lactobacillus)属の乳酸菌;カルノバクテリウム ディバージェンス(Carnobacterium
divergens)、カルノバクテリウム ピシコーラ(Carnobacterium piscicola)等のカルノバクテリウム(Carnobacterium)属の乳酸菌;ロイコノストック メセンテロイズ(Leuconostoc
mesenteroides)、ロイコノストック シトレウム(Leuconostoc citreum)等のロイコノストック(Leuconostoc)属の乳酸菌; ストレプトコッカス フェーカリス(Streptococcus
faecalis)、ストレプトコッカス ピオジェネス(Streptococcus pyogenes)等のストレプトコッカス属の乳酸菌;エンテロコッカス
カゼリフラバス(Enterococcus caseliflavus)、エンテロコッカス サルフレウス(Enterococcus sulfreus)等のエンテロコッカス(
Enterococcus)属の乳酸菌;ラクトコッカス プランタラム(Lactococcus
plantarum) ラクトコッカス ラフィノラクティス(Lactococcus rafinolactis)等のラクトコッカス属の乳酸菌;ヴェイセラ
コンフューザ(Weissella confusa)、ヴェイセラ カンドウレリ(Weissella kandleri)等のヴェイセラ属の乳酸菌;アトポビウム ミニュタム(Atopobium minutum)、アトポビウム パービュラス(Atopobiumparvulus)等のアトポビウム(Atopobium)属の乳酸菌;バゴコッカス フルビアリス(Vagococcus
fluvialis)、バゴコッカス サーモニナラム(Vagococcus salmoninarum)等のバゴコッカス(Vagococcus)属の乳酸菌;ペディオコッカス ダムノサス(Pediococcus
damnosus)、ペディオコッカス ペントサセウス(Pediococcus pentosaceus)等のペディオコッカス(Pediococcus)属の乳酸菌等が挙げられる。それら乳酸菌のうちでも、得られる発酵物の皮膚生理活性の観点とさらに極端な嫌気性でなく取り扱い易いという点から、ラクトバシルス
プランタラム(Lactobacillus plantarum)の使用が最も好ましい。
Examples of lactic acid bacteria include Lactobacillus plantarum, L. brevis, L. casei and other Lactobacillus lactic acid bacteria; Carnobacterium divergence (Carnobacterium
divergens), lactic acid bacteria of the genus Carnobacterium such as Carnobacterium piscicola; Leuconostoc (Leuconostoc)
mesenteroides), lactic acid bacteria of the genus Leuconostoc such as Leuconostoc citreum; Streptococcus faecalis (Streptococcus)
faecalis), Streptococcus pyogenes and other Streptococcus lactic acid bacteria; Enterococcus caseliflavus, Enterococcus sulfreus and other Enterococcus sulfreus enterococcus (
Enterococcus) lactic acid bacteria; Lactococcus plantarum (Lactococcus)
lactic acid bacteria of the genus Lactococcus such as Lactococcus rafinolactis; Weissella confusa, lactic acid bacteria of the genus Weissella kandleri; Atopobium mintopum ) Lactic acid bacteria of the genus Atopobium; Vagococcus flubiaris (Vagococcus)
lactic acid bacteria of the genus Vagococcus such as fluvialis), Vagococcus salmoninarum; Pediococcus damnosus
damnosus), Pediococcus pentosaceus, and other lactic acid bacteria belonging to the genus Pediococcus. Among these lactic acid bacteria, the use of Lactobacillus plantarum is most preferable from the viewpoint of the skin physiological activity of the obtained fermented product and the ease of handling without being extremely anaerobic.
麹菌としては、例えばアスペルギルス オリゼー(Aspergillus oryzae)、アスペルギルス
フラバス(Aspergillus flavus)、アスペルギルス ポリオキソジェネス(Aspergillus polyoxogenes)、アスペルギルス ソーヤ(Aspergillus
sojae)等の黄麹菌、アスペルギルス アワモリ(Aspergillus awamori)、アスペルギルス
カワウチ(Aspergillus kawauchii)、アスペルギルス ウサミ(Aspergillus usami)、
アスペルギルス ニガー(Aspergillus niger)等の黒麹菌、モナスカス アンカ(Monascus anka)、モナスカス ピロサス(Monascus pilosus)等の紅麹菌などが挙げられる。それらのうちでも、得られる発酵物の皮膚生理活性の観点とさらに発酵液の着色や発酵臭が比較的少ないことから、アスペルギルス
オリゼー(Aspergillus oryzae)が最も好ましい。
As the koji mold, for example, Aspergillus oryzae, Aspergillus flavus, Aspergillus polyoxogenes, Aspergillus soya (Aspergillus soy)
sojae), Aspergillus awamori, Aspergillus kawauchii, Aspergillus usami,
Examples include black koji molds such as Aspergillus niger, Monascus anka, and Monascus pilosus. Among them, Aspergillus oryzae is most preferable from the viewpoint of the skin physiological activity of the obtained fermented product and the relatively low coloring and fermentation odor of the fermentation broth.
納豆菌としては、例えばバシルス ナットー(Bacillus natto)、バシルス サブチルス(Bacillus subtilis)、バシルス サーキュランス(Bacillus
circulans)等のバシルス属の細菌などが挙げられる。なかでも、食品に広く使用されており、安全性が高い点でバシルス ナットー(Bacillus natto)が最も好ましい。
Examples of Bacillus natto include Bacillus natto, Bacillus subtilis, Bacillus circulans (Bacillus
bacterium of the genus Bacillus such as circulans). Among these, Bacillus natto is most preferable because it is widely used in foods and has high safety.
テンペ菌としては、リゾプス アジゴスポラス(Rhizopus azygosporus)、リゾプス
ミクロスポラス チネンシス(Rhizopus microsporus chinensis)、リゾプス ミクロスポラス
オリゴスポラス(Rhizopus microsporus oligosporus)、リゾプス ニベウス(Rhizopus niveus)、リゾプス オリゼー(Rhizopus oryzae)等のリゾプス菌の真菌(カビ)が挙げられる。なかでも、インドネシアをはじめ東南アジア地域で発酵食品に広く使用されており、安全性が高い点で、リゾプス
ミクロスポラス オリゴスポラス(Rhizopus microsporus oligosporus)やリゾプス オリゼー(Rhizopus oryzae)が最も好ましい。
Tempe fungi include Rhizopus azygosporus, Rhizopus microsporus chinensis, Rhizopus microsporus oligosporus, Rhizopus microsporus oligosporus, Rhizopus microsporus oligosporus, Rhizopus microsporus oligosporus, Rhizopus microsporus oligosporus Examples include fungi of the fungus. Among them, Rhizopus microsporus oligosporus and Rhizopus oryzae are most preferable because they are widely used for fermented foods in Southeast Asia including Indonesia.
酵母としては、例えばサッカロミセス セレビシエ(Saccharomyces cerevisiae)、サッカロミセス
アワモリ(Saccharomyces awamori)、サッカロミセス チェバリエリ(Saccharomyces chevalieri)、サッカロミセス カールスバージェンシス(Saccharomyces carlsbergensis)、サッカロミセス バヨナス(Saccharomyces
bayon us)等のサッカロミセス属の酵母、トルラスポラ デルブルエキ(Torulaspora delbruekii)、トルラスポラ
ファーメンタチ(Torulaspora fermentati)、トルラスポラ ロゼイ(Torulaspora rosei)等のトルラスポラ属の酵母、ジゴサッカロミセス ローキシ(Zygosaccharomyces rouxii)、ジゴサッカロミセス ソーヤ(Zygosaccharomyces
soya)、ジゴサッカロミセス サケ(Zygosaccharomyces sake)、ジゴサッカロミセス
ミソ(Zygosaccharomyces miso)、ジゴサッカロミセス ラクティス(Zygosaccharomyces lactis)等のジゴサッカロミセス属の酵母、カンディダ ベルサチリス(Candida versatilis)、カンディダ エチェリシイ(Candida
etchellsii)、カンディダ ケフィール(Candida kefyr)、カンディダ サケ(Candida sake)、カンディダ スコッティ(Candida scottii)等のカンディダ属の酵母、オーレオバシディウム
プルランス(Aureobasidium Pullulans)、オーレオバシディウム マンソニー(Aureobasidium mansonii)、オーレオバシディウム マイクロスティクタム(Aureobasideium microstictum)等のオーレオバシディウム属の酵母などが挙げられる。それらのうちでも、食品に最も広く利用され、発酵力が強いという点からサッカロミセス
セレビシエ(Saccharomyces cerevisiae)が最も好ましい。
Examples of the yeast include Saccharomyces cerevisiae, Saccharomyces awamori, Saccharomyces chevalieri, Saccharomyces carlsbergences, Saccharomyces carlsbergences,
bayon us), Saccharomyces yeast, Torulaspora delbruekii, Torulaspora fermentati, Torulaspora rosei, Torulaspora rosei, etc. Soya (Zygosaccharomyces
soy), Zygosaccharomyces sake, Zygosaccharomyces miso, Zygosaccharomyces lactis, etc.
etchellsii), Candida kefyr, Candida sake, Candida scottii and other yeasts of the genus Candida, Aureobasidium Pullulans, Aureobasidium mansonii ), Yeast of the genus Aureobasidium such as Aureobasideium microstictum. Among them, Saccharomyces cerevisiae is most preferable because it is most widely used for foods and has a strong fermenting power.
上記の微生物を用いて植物を発酵させる方法の好ましい具体例を挙げれば以下の通りである。まず、発酵しようとする植物(以下、発酵素材ということがある)を溶媒に浸漬又は懸濁させて、発酵のための懸濁液を調製する。この場合、植物は生のまま用いても、又予め乾燥もしくは半乾燥した上用いてもよい。又、形状としては、採取したものをそのまま用いることもできるが、細断或いは粉砕して微細化すれば発酵効率を上げることができる。 Preferable specific examples of the method for fermenting a plant using the above microorganisms are as follows. First, a suspension for fermentation is prepared by immersing or suspending a plant to be fermented (hereinafter sometimes referred to as a fermentation material) in a solvent. In this case, the plant may be used as it is, or may be used after previously dried or semi-dried. In addition, as for the shape, the collected one can be used as it is, but the fermentation efficiency can be increased if it is shredded or pulverized and refined.
発酵素材を懸濁させるための溶媒としては、水或いは水と低級アルコール類(メタノール、エタノール、プロパノールなど)もしくはグリコール類(エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなど)との混液等が用いられ、又それら溶媒中にはグルコース、フルクトース、シュークロースなどの糖類を添加してもよいが、微生物が最もその作用を発揮しやすい点と植物の成分以外の資化成分の存在に基づく発酵副産物の生成を避けるという点から、水を単独で用いるのが特に好ましい。 As a solvent for suspending the fermentation material, water or a mixture of water and lower alcohols (methanol, ethanol, propanol, etc.) or glycols (ethylene glycol, propylene glycol, 1,3-butylene glycol, glycerin, etc.) In these solvents, sugars such as glucose, fructose and sucrose may be added. However, in view of the fact that microorganisms are most likely to exert their action and there are assimilation components other than plant components. It is particularly preferred to use water alone, in order to avoid the production of fermented by-products based on it.
この発酵素材/溶媒懸濁液は、これを発酵工程に供する前に、殺菌を行って発酵の障害となる雑菌を除去することが必要であるが、この雑菌の殺菌除去方法としては、発酵素材を予め殺菌用エタノール等で洗浄した後無菌水等の無菌溶媒に懸濁する方法を用いてもよく、又発酵素材を溶媒に懸濁した後、懸濁液を加熱殺菌等により殺菌するようにしてもよい。加熱殺菌処理としては、懸濁液を120〜130℃で10〜20分間加熱するオートクレーブ殺菌法や、80〜90℃に60〜120分間保持することを1日1回2〜3日間繰り返す間断殺菌法といった加熱殺菌法が一般に用いられる。 Before the fermentation material / solvent suspension is subjected to a fermentation process, it is necessary to sterilize and remove the germs that hinder the fermentation. May be used by washing with ethanol for sterilization in advance and then suspending in a sterile solvent such as sterile water. May be. As the heat sterilization treatment, the autoclave sterilization method in which the suspension is heated at 120 to 130 ° C. for 10 to 20 minutes, or holding at 80 to 90 ° C. for 60 to 120 minutes is repeated once a day for 2 to 3 days. The heat sterilization method such as the method is generally used.
次に、この無菌化した懸濁液を発酵タンクに入れ、これに微生物を植菌して発酵させる。微生物の接種量は107〜108個/mLが適量である。接種量が上記の範囲より多くなっても発酵の進行時間は殆ど変わらず、一方上記の範囲より少なくなると発酵完了までに長時間を要することとなって好ましくない。 Next, the sterilized suspension is placed in a fermentation tank, and microorganisms are inoculated into the fermentation tank for fermentation. The appropriate amount of inoculated microorganism is 10 7 to 10 8 cells / mL. Even if the inoculation amount exceeds the above range, the fermentation progress time hardly changes. On the other hand, if the inoculation amount is less than the above range, it takes a long time to complete the fermentation.
発酵温度は一般に5〜50℃の範囲、好ましくは各微生物の生育至適温度である30〜40℃(例えば、乳酸菌であれば35℃〜40℃)の範囲である。発酵日数は、至適温度に於いて一般に1〜10日、好ましくは2〜5日の範囲である。発酵日数が上記の一般的範囲より短くなると発酵が十分に行われず発酵物の有効性が低下する傾向にあり、一方10日を越えて長くしても有効性のそれ以上の上昇は認められないだけでなく、着色や発酵臭の増加が生ずることとなっていずれも好ましくない。 The fermentation temperature is generally in the range of 5 to 50 ° C., preferably in the range of 30 to 40 ° C. (for example, 35 ° C. to 40 ° C. for lactic acid bacteria), which is the optimum temperature for growth of each microorganism. The number of days of fermentation is generally in the range of 1 to 10 days, preferably 2 to 5 days, at the optimum temperature. If the fermentation days are shorter than the above general range, the fermentation is not sufficiently performed and the effectiveness of the fermented product tends to be reduced. On the other hand, if the fermentation days are longer than 10 days, no further increase in effectiveness is observed. Not only that, but also coloring and an increase in fermentation odor occur.
以上の発酵処理を行うに当たって、植物の成分が微生物によってより有効に利用されるようにするため、微生物の植菌前もしくは植菌と同時に、前記の懸濁液に酵素を添加して、植物に酵素による加水分解処理を施してもよい。この場合、使用する酵素としては、上述した蛋白分解酵素、澱粉分解酵素、繊維素分解酵素、及び脂質分解酵素が挙げられる。 In performing the above fermentation treatment, an enzyme is added to the suspension before or at the time of inoculation of microorganisms so that plant components can be used more effectively by microorganisms. Hydrolysis treatment with an enzyme may be performed. In this case, examples of the enzyme to be used include the above-mentioned proteolytic enzymes, amylolytic enzymes, fibrinolytic enzymes, and lipolytic enzymes.
以上のようにして得られる発酵物は、ろ過などの固液分離操作を行い、液相部分と固相部分に分離する。分離した液相部分及び固相部分のいずれを使用しても良く、例えば、米の発酵物に関しては、固相部分を乾燥して、粉末化した上で使用してもよい。 The fermented product obtained as described above is subjected to a solid-liquid separation operation such as filtration to be separated into a liquid phase portion and a solid phase portion. Any of the separated liquid phase portion and solid phase portion may be used. For example, regarding the fermented rice, the solid phase portion may be dried and powdered.
本発明の化粧料は、3種以上の植物を組み合わせて配合してなるものであるが、それら成分の配合比は、米の抽出物、加水分解物または発酵物の10重量部に対して、ブラシカ属の植物の抽出物、加水分解物または発酵物が一般には0.1〜100重量部、好ましくは1〜50重量部、又ハス属植物の抽出物、加水分解物または発酵物が一般には0.1〜50重量部、好ましくは1〜30重量部、又ハトムギの抽出物、加水分解物または発酵物が一般には0.1〜100重量部、好ましくは1〜30重量部の範囲である。又、化粧料中における各植物成分の配合量は、化粧料の用途、適用部位によっても異なるが、固形分換算で、0.0001重量%〜10.0重量%、好ましくは0.001〜5.0重量%である。 The cosmetic of the present invention is formed by combining three or more kinds of plants, but the mixing ratio of these components is 10 parts by weight of the rice extract, hydrolyzate or fermented product. The extract, hydrolyzate or fermented product of Brassica plant is generally 0.1 to 100 parts by weight, preferably 1 to 50 parts by weight, and the extract, hydrolyzate or fermented product of Lotus species is generally used. 0.1 to 50 parts by weight, preferably 1 to 30 parts by weight, and pearl barley extract, hydrolyzate or fermented product is generally in the range of 0.1 to 100 parts by weight, preferably 1 to 30 parts by weight. . The amount of each plant component in the cosmetic varies depending on the use and application site of the cosmetic, but is 0.0001% to 10.0% by weight, preferably 0.001 to 5% in terms of solid content. 0.0% by weight.
さらに、本発明に於いては、さらに、美白剤、保湿剤、表皮細胞賦活剤、線維芽細胞賦活剤、抗酸化剤、抗炎症剤、及び血行促進剤のうちのいずれか1種以上を有することが好ましい。 Furthermore, in the present invention, it further includes any one or more of a whitening agent, a moisturizing agent, an epidermal cell activator, a fibroblast activator, an antioxidant, an anti-inflammatory agent, and a blood circulation promoter. It is preferable.
まず、美白剤としては、t−シクロアミノ酸誘導体、コウジ酸及びその誘導体、アスコルビン酸及びその誘導体、ハイドロキノン又はその誘導体、エラグ酸及びその誘導体、ニコチン酸及びその誘導体、レゾルシノール誘導体、トラネキサム酸及びその誘導体、4−メトキシサリチル酸カリウム塩、マグノリグナン(5,5'−ジプロピル−ビフェニル−2,2’−ジオール)、4−HPB(ロドデノール、4−(4−ヒドロキシフェニル)−4−ブタノール))、AMP(アデノシンモノホスフェイト、アデノシン1リン酸)が挙げられ、これらを単独で配合しても、複数を組み合わせて配合しても良い。 First, whitening agents include t-cycloamino acid derivatives, kojic acid and derivatives thereof, ascorbic acid and derivatives thereof, hydroquinone or derivatives thereof, ellagic acid and derivatives thereof, nicotinic acid and derivatives thereof, resorcinol derivatives, tranexamic acid and derivatives thereof 4-methoxysalicylic acid potassium salt, magnolignan (5,5'-dipropyl-biphenyl-2,2'-diol), 4-HPB (rhodenol, 4- (4-hydroxyphenyl) -4-butanol)), AMP (Adenosine monophosphate, adenosine monophosphate) may be mentioned, and these may be blended singly or in combination.
上記のコウジ酸誘導体としては、例えばコウジ酸モノブチレート、コウジ酸モノカプレート、コウジ酸モノパルミテート、コウジ酸ジブチレートなどのコウジ酸エステル類、コウジ酸エーテル類、コウジ酸グルコシドなどのコウジ酸糖誘導体等が、アスコルビン酸誘導体としては、例えばL−アスコルビン酸−2−リン酸エステルナトリウム、L−アスコルビン酸−2−リン酸エステルマグネシウム、L−アスコルビン酸−2−硫酸エステルナトリウム、L−アスコルビン酸−2−硫酸エステルマグネシウムなどのアスコルビン酸エステル塩類、L−アスコルビン酸−2−グルコシド(2−O−α−D−グルコピラノシル−L−アスコルビン酸)、L−アスコルビン酸−5−グルコシド(5−O−α−D−グルコピラノシル−L−アスコルビン酸)などのアスコルビン酸糖誘導体、それらアスコルビン酸糖誘導体の6位アシル化物(アシル基は、ヘキサノイル基、オクタノイル基、デカノイル基など)、L−アスコルビン酸テトライソパルミチン酸エステル、L−アスコルビン酸テトララウリン酸エステルなどのL−アスコルビン酸テトラ脂肪酸エステル類、3−O−エチルアスコルビン酸、L−アスコルビン酸−2−リン酸−6−O−パルミテートナトリウム等が、ハイドロキノン誘導体としては、アルブチン(ハイドロキノン−β−D−グルコピラノシド)、α−アルブチン(ハイドロキノン−α−D−グルコピラノシド)等が、トラネキサム酸誘導体としては、トラネキサム酸エステル(例えば、トラネキサム酸ラウリルエステル、トラネキサム酸ヘキサデシルエステル、トラネキサム酸セチルエステル又はその塩)、トラネキサム酸のアミド体(例えば、トラネキサム酸メチルアミド)などが挙げられ、レゾルシノール誘導体としては、例えば、4−n−ブチルレゾルシノール、4−イソアミルレゾルシノール等が、2,5−ジヒドロキシ安息香酸誘導体としては、例えば2,5−ジアセトキシ安息香酸、2−アセトキシ−5−ヒドロキシ安息香酸、2−ヒドロキシ−5−プロピオニルオキシ安息香酸等が、ニコチン酸誘導体としては、例えばニコチン酸アミド、ニコチン酸ベンジル等が、ビタミンE誘導体としては、例えばビタミンEニコチネート、ビタミンEリノレート等が、α−ヒドロキシ酸としては、例えば乳酸、リンゴ酸、コハク酸、クエン酸、α−ヒドロキシオクタン酸等がある。 Examples of the kojic acid derivatives include kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid dibutyrate, kojic acid ethers, kojic acid sugar derivatives such as kojic acid glucoside, etc. However, as the ascorbic acid derivatives, for example, L-ascorbic acid-2-phosphate sodium, L-ascorbic acid-2-phosphate magnesium, L-ascorbic acid-2-sulfate sodium, L-ascorbic acid-2 -Ascorbic acid ester salts such as magnesium sulfate, L-ascorbic acid-2-glucoside (2-O-α-D-glucopyranosyl-L-ascorbic acid), L-ascorbic acid-5-glucoside (5-O-α) -D-glucopyranosyl-L-ascorbine Acid) ascorbic acid sugar derivatives, acylated 6-positions of these ascorbic acid sugar derivatives (acyl groups are hexanoyl, octanoyl, decanoyl, etc.), L-ascorbic acid tetraisopalmitate, L-ascorbic acid tetra L-ascorbic acid tetrafatty acid esters such as lauric acid ester, 3-O-ethylascorbic acid, L-ascorbic acid-2-phosphate-6-O-palmitate sodium and the like are hydroquinone derivatives such as arbutin (hydroquinone). -Β-D-glucopyranoside), α-arbutin (hydroquinone-α-D-glucopyranoside) and the like as tranexamic acid derivatives, tranexamic acid esters (for example, tranexamic acid lauryl ester, tranexamic acid hexadecyl ester, trane And amides of tranexamic acid (for example, tranexamic acid methylamide). Resorcinol derivatives include, for example, 4-n-butylresorcinol, 4-isoamylresorcinol, and the like. Examples of the -dihydroxybenzoic acid derivative include 2,5-diacetoxybenzoic acid, 2-acetoxy-5-hydroxybenzoic acid, and 2-hydroxy-5-propionyloxybenzoic acid. Examples of the nicotinic acid derivative include nicotinic acid amide. Benzyl nicotinate and the like, vitamin E derivatives such as vitamin E nicotinate and vitamin E linoleate, and α-hydroxy acids such as lactic acid, malic acid, succinic acid, citric acid, and α-hydroxyoctanoic acid is there.
又、植物、海藻及び動物などの天然物由来の美白剤として、ユキノシタ、ムラサキシキブ、クワ、ヒカゲノツルニンジン、カミツレ、シャクヤク、ボタン、ローヤルゼリー、米糠、酒粕、緑藻、褐藻、紅藻、アマモなどの抽出物、加水分解物又は発酵物、胎盤抽出液などが挙げられる。上記植物の使用部位としては、全草、花、萼、蕾、種子、果実、果皮、葉、茎、根、根皮などいずれでも良い。例えば、ヒカゲノツルニンジンであれば根(党参)、クワであれば根皮、シャクヤクであれば花や根、ボタンであれば花や根皮(ボタンピ)などが挙げられるが、本発明はこれに限るものではない。 In addition, as a whitening agent derived from natural products such as plants, seaweeds and animals, extraction of cypress, murasakixibu, mulberry, lacquered carrot, chamomile, peonies, buttons, royal jelly, rice bran, sake lees, green algae, brown algae, red algae, amamo, etc. Product, hydrolyzate or fermented product, placenta extract and the like. The use part of the plant may be whole grass, flowers, buds, persimmons, seeds, fruits, pericarps, leaves, stems, roots, root barks and the like. For example, the root carrot is a root (participant), a mulberry is a root bark, a peony is a flower or root, and a button is a flower or root bark (button pi). It is not limited.
又、表皮細胞賦活剤としては、ナス(水ナス、賀茂ナス、長ナス、米ナス等)、ハイビスカス、イネ、サンショウ、サンゴ草、緑藻、褐藻、紅藻、クラゲなどの抽出物、加水分解物又は発酵物が挙げられる。上記植物の使用部位としては、全草、花、萼、蕾、種子、果実、果皮、葉、茎、根、根皮などいずれでも良く、例えば、ナスであれば果実、ハイビスカスであれば花、萼、イネであれば葉、サンショウであれば種子などが挙げられるが、本発明はこれに限るものではない。 In addition, as epidermal cell activators, eggplant (water eggplant, Kamo eggplant, long eggplant, rice eggplant, etc.), hibiscus, rice, salamander, coral grass, green algae, brown algae, red algae, jellyfish and other extracts, hydrolysis Product or fermented product. The use part of the plant may be whole grass, flowers, buds, persimmons, seeds, fruits, pericarps, leaves, stems, roots, root barks, etc., for example, fruits for eggplants, flowers for hibiscus, In the case of rice and rice, examples include leaves, and in the case of salamander, seeds and the like. However, the present invention is not limited thereto.
又、線維芽細胞賦活剤としては、フノリ、アマモ、ナス(水ナス、賀茂ナス、長ナス、米ナス等)、マンゴスチン、マンゴー、チェリモヤ、ローヤルゼリー、酒粕などの抽出物、加水分解物又は発酵物が挙げられる。上記植物の使用部位としては、全草、花、萼、種子、果実、果皮、葉、茎、根、根皮などいずれでも良く、例えば、ナス、マンゴスチン、マンゴー、チェリモヤであれば果実などが挙げられるが、本発明はこれに限るものではない。 In addition, as a fibroblast activator, funori, amamo, eggplant (water eggplant, Kamo eggplant, long eggplant, rice eggplant, etc.), mangosteen, mango, cherimoya, royal jelly, liquor and other extracts, hydrolysates or fermented products Is mentioned. The use part of the plant may be whole grass, flowers, persimmons, seeds, fruits, pericarps, leaves, stems, roots, root barks, etc., for example, eggplant, mangosteen, mango, cherimoya fruit etc. However, the present invention is not limited to this.
又、保湿剤としては、ヘチマ、アロエ、アマモ、緑藻、褐藻、紅藻、クラゲなどの抽出物、加水分解物又は発酵物が挙げられる。上記植物の使用部位としては、全草、花、萼、蕾、種子、果実、果皮、葉、茎、根、根皮などいずれでも良く、例えば、ヘチマであれば果実などが挙げられるが、本発明はこれに限るものではない。 Examples of the moisturizing agent include extracts such as loofah, aloe, amamo, green algae, brown algae, red algae and jellyfish, hydrolysates or fermented products. The use part of the plant may be whole grass, flowers, buds, persimmons, seeds, fruits, pericarps, leaves, stems, roots, root barks, etc. The invention is not limited to this.
又、抗炎症剤としては、ゲンチアナ、パウダルコ、ワスレグサ、カミツレ、ジュアゼイロなどの抽出物、加水分解物又は発酵物が挙げられる。上記植物の使用部位としては、全草、花、萼、種子、蕾、果実、果皮、葉、茎、根、根皮などいずれでも良く、例えば、ゲンチアナであれば根、パウダルコであれば樹皮、ワスレグサであれば花、蕾、カミツレであれば花、ジュアゼイロであれば樹皮などが挙げられるが、本発明はこれに限るものではない。 Examples of the anti-inflammatory agent include extracts such as gentian, paudalco, forget-me-not, chamomile, juazeiro, hydrolyzate, or fermented product. The use part of the above plant may be whole grass, flowers, persimmons, seeds, persimmons, fruits, pericarps, leaves, stems, roots, root barks, etc., for example, roots for gentian, bark for powdarco, In the case of forget-me-not, flowers, buds, in the case of chamomiles, in the case of flowers, and in the case of juazeiro, the bark, etc. may be mentioned, but the present invention is not limited thereto.
又、抗酸化剤としては、ニンジン、イネ、シャクヤク、ボタン、クワ、ユリ、ムラサキシキブ、豆乳などの抽出物、加水分解物又は発酵物が挙げられる。上記植物の使用部位としては、全草、花、萼、種子、蕾、果実、果皮、葉、茎、根、根皮などいずれでも良く、例えば、ニンジン(西洋ニンジン、朝鮮人参(トチバニンジンやオタネニンジンなど)、竹節人参、田七人参などのいずれの人参でもよい)であれば根、イネであれば葉、シャクヤクであれば花、根、ボタンであれば花、根皮、ユリであれば花、蕾、ムラサキシキブであれば果実などが挙げられるが、本発明はこれに限るものではない。 Antioxidants include extracts such as carrots, rice, peonies, buttons, mulberries, lilies, murasakikibu, soy milk, hydrolysates or fermented products. The plant may be used in whole plants, flowers, persimmons, seeds, persimmons, fruits, pericarps, leaves, stems, roots, root barks, etc., such as carrots (western carrots, ginseng (spotted carrots, ginsengs, etc.) ), Bamboo ginseng, rice ginseng, etc.) if root, leaf if rice, blossom if peonies, root, flowers if roots, buttons, root bark, flowers if lily, In the case of persimmon and murasakikib, examples include fruits, but the present invention is not limited thereto.
又、血行促進剤としては、タマサキツヅラフジが挙げられる。タマサキツヅラフジであれば根の使用が好ましいが、本発明はこれに限るものではない。 In addition, examples of the blood circulation promoter include Tamazaki Rafuji. The use of roots is preferable in the case of Tamatsuki tsumugi, but the present invention is not limited to this.
又、本発明は、本発明の化粧料には、さらに、通常化粧料に用いられる成分、例えば油性成分、界面活性剤(合成系、天然物系)、保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収剤、抗酸化剤、キレート剤、色素、香料等を必要に応じて適宜配合することができる。また、本発明の組成物の有効性、特長を損なわない限り、他の生理活性成分と組み合わせて化粧料に配合することも何ら差し支えない。 In addition, the present invention further includes components usually used in cosmetics such as oil components, surfactants (synthetic and natural products), moisturizers, thickeners, antiseptics and sterilizers. An agent, a powder component, an ultraviolet absorber, an antioxidant, a chelating agent, a dye, a fragrance and the like can be appropriately blended as necessary. Moreover, as long as the effectiveness and characteristics of the composition of the present invention are not impaired, it may be combined with other physiologically active ingredients in cosmetics.
ここで、油性成分としては、例えばオリーブ油、ホホバ油、ヒマシ油、大豆油、米油、米胚芽油、ヤシ油、パーム油、カカオ油、メドウフォーム油、シアーバター、ティーツリー油、アボガド油、マカデミアナッツ油、植物由来スクワランなどの植物由来の油脂類;ミンク油、タートル油などの動物由来の油脂類;ミツロウ、カルナウバロウ、ライスワックス、ラノリンなどのロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワランなどの炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、cis−11−エイコセン酸などの脂肪酸類;ラウリルアルコール、セタノール、ステアリルアルコールなどの高級アルコール類;ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オレイン酸ブチル、2−エチルヘキシルグリセライド、高級脂肪酸オクチルドデシル(ステアリン酸オクチルドデシル等)などの合成エステル類及び合成トリグリセライド類等が挙げられる。 Here, as the oil component, for example, olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, palm oil, palm oil, cacao oil, meadow foam oil, sheer butter, tea tree oil, avocado oil, Oils derived from plants such as macadamia nut oil and plant-derived squalane; Fats derived from animals such as mink oil and turtle oil; waxes such as beeswax, carnauba wax, rice wax, lanolin; liquid paraffin, petrolatum, paraffin wax, squalane, etc. Hydrocarbons; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, cis-11-eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol, stearyl alcohol; isopropyl myristate, palmitic acid Isopropyl, me Butyl phosphate, 2-ethylhexyl glycerides, higher fatty acid octyldodecyl (octyl stearate dodecyl and the like), and the synthetic esters and synthetic triglycerides such like.
界面活性剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステルなどの非イオン界面活性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、α−スルホン化脂肪酸アルキルエステル塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩などのアニオン界面活性剤;第四級アンモニウム塩、第一級〜第三級脂肪アミン塩、トリアルキルベンジルアンモニウム塩、アルキルピリジニウム塩、2−アルキル−1−アルキル−1−ヒドロキシエチルイミダゾリニウム塩、N,N−ジアルキルモルフォルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩などのカチオン界面活性剤;N,N−ジメチル−N−アルキル−N−カルボキシメチルアンモニオベタイン、N,N,N−トリアルキル−N−アルキレンアンモニオカルボキシベタイン、N−アシルアミドプロピル−N′,N′−ジメチル−N′−β−ヒドロキシプロピルアンモニオスルホベタインなどの両性界面活性剤等を使用することができる。
また、乳化剤乃至乳化助剤として、酵素処理ステビアなどのステビア誘導体、レシチン及びその誘導体、乳酸菌発酵米、乳酸菌発酵発芽米、乳酸菌発酵穀類(麦類、豆類、雑穀など)、ジュアゼイロ(Rhamnaceae zizyphus joazeiro)抽出物等を配合することもできる。
Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene Nonionic surfactants such as oxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ether sulfates, Polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene alkyl phenyl ether phosphates, Quaternary ammonium salt, primary to tertiary fatty amine salt, trialkylbenzylammonium salt, alkylpyridinium salt, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salt, N N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N, N, N-trialkyl-N-, N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine Amphoteric surfactants such as alkylene ammoniocarboxybetaine and N-acylamidopropyl-N ′, N′-dimethyl-N′-β-hydroxypropylammoniosulfobetaine can be used.
In addition, as emulsifiers or emulsifiers, stevia derivatives such as enzyme-treated stevia, lecithin and its derivatives, lactic acid bacteria fermented rice, lactic acid bacteria fermented germinated rice, lactic acid bacteria fermented cereals (wheat, legumes, cereals, etc.), juzairo (Rhamnaceae zizyphus joazeiro) An extract or the like can also be blended.
保湿剤としては、例えばグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール、ソルビトール、キシリトール、ピロリドンカルボン酸ナトリウム等があり、さらにトレハロース等の糖類、ムコ多糖類(例えば、ヒアルロン酸及びその誘導体、コンドロイチン及びその誘導体、ヘパリン及びその誘導体など)、エラスチン及びその誘導体、コラーゲン及びその誘導体、NMF関連物質、乳酸、尿素、高級脂肪酸オクチルドデシル、魚介類由来コラーゲン及びその誘導体、各種アミノ酸及びそれらの誘導体が挙げられる。 Examples of the humectant include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate, and sugars such as trehalose, mucopolysaccharides (for example, hyaluron). Acid and derivatives thereof, chondroitin and derivatives thereof, heparin and derivatives thereof, elastin and derivatives thereof, collagen and derivatives thereof, NMF related substances, lactic acid, urea, higher fatty acid octyldodecyl, seafood-derived collagen and derivatives thereof, various amino acids And their derivatives.
増粘剤としては、例えばアルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻又は紅藻由来成分;ペクチン、ローカストビーンガム、アロエ多糖体等の多糖類;キサンタンガム、トラガントガム、グアーガム等のガム類;カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体;ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸及びその誘導体;ポリグルタミン酸及びその誘導体等が挙げられる。 Examples of the thickener include components derived from brown algae, green algae or red algae such as alginic acid, agar, carrageenan and fucoidan; polysaccharides such as pectin, locust bean gum and aloe polysaccharide; gums such as xanthan gum, tragacanth gum and guar gum; Cellulose derivatives such as methyl cellulose and hydroxyethyl cellulose; synthetic polymers such as polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, acrylic acid / methacrylic acid copolymer; hyaluronic acid and derivatives thereof; polyglutamic acid and derivatives thereof.
防腐・殺菌剤としては、例えば尿素;パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチルなどのパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャマール(イミダゾデイニールウレア)、1,2−ペンタンジオール、各種精油類、樹皮乾留物等がある。 Examples of the antiseptic / bactericidal agent include urea; paraoxybenzoates such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophene, hexachlorophene, chlorhexidine hydrochloride, benzaza chloride Luconium, salicylic acid, ethanol, undecylenic acid, phenols, jamal (imidazodenyl urea), 1,2-pentanediol, various essential oils, bark dry matter, and the like.
粉体成分としては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパウダー、ポリエチレンパウダー、シルクパウダー、セルロース系パウダー、穀類(米、麦、トウモロコシ、キビなど)のパウダー、豆類(大豆、小豆など)のパウダー等がある。 Examples of powder components include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, polyethylene powder, silk powder, and cellulose. System powders, powders of cereals (rice, wheat, corn, millet, etc.), powders of beans (soybeans, red beans, etc.).
紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸2−エチルヘキシル、桂皮酸オクチル、オキシベンゾン、2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−ターシャリーブチル−4−メトキシベンゾイルメタン、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル、アロエ抽出物等がある。 Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, 2-ethylhexyl paramethoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy-4 -Methoxybenzophenone-5-sulfonate, 4-tertiarybutyl-4-methoxybenzoylmethane, 2- (2-hydroxy-5-methylphenyl) benzotriazole, urocanic acid, ethyl urocanate, aloe extract, etc. .
抗酸化剤としては、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ビタミンE及びその誘導体等がある。 Examples of the antioxidant include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and derivatives thereof.
キレート剤としては、例えばエチレンジアミンヒドロキシエチル三酢酸三ナトリウム、エデト酸又はその塩類、グルコン酸、フィチン酸、ポリリン酸ナトリウム、メタリン酸ナトリウム、ヒドロキシエタンジホスホ酸四ナトリウムなどがある。 Examples of chelating agents include trisodium ethylenediaminehydroxyethyl triacetate, edetic acid or salts thereof, gluconic acid, phytic acid, sodium polyphosphate, sodium metaphosphate, tetrasodium hydroxyethane diphosphonate, and the like.
生理活性成分としては、例えば、リノール酸及びその誘導体もしくは加工物(例えばリポソーム化リノール酸など)、2,5−ジヒドロキシ安息香酸誘導体が、又皮膚老化防止・美肌化成分として、動物又は魚由来のコラーゲン及びその誘導体、エラスチン及びその誘導体、グリチルリチン酸及びその誘導体(ジカリウム塩等)、t−シクロアミノ酸誘導体、ビタミンA及びその誘導体、ビタミンE及びその誘導体、アラントイン、α−ヒドロキシ酸類、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸などがある。 As the physiologically active ingredient, for example, linoleic acid and its derivatives or processed products (for example, liposomal linoleic acid), 2,5-dihydroxybenzoic acid derivatives are also used as skin aging preventing / beautifying ingredients, derived from animals or fish. Collagen and derivatives thereof, elastin and derivatives thereof, glycyrrhizic acid and derivatives thereof (dipotassium salt, etc.), t-cycloamino acid derivatives, vitamin A and derivatives thereof, vitamin E and derivatives thereof, allantoin, α-hydroxy acids, diisopropylamine dichloroacetate And γ-amino-β-hydroxybutyric acid.
本発明の組成物を含む化粧料(医薬部外品を含む)適用部位としては、頭皮を含む皮膚全般が挙げられ、特に制限はない。従って、剤形としては、乳液、クリーム、ローション、エッセンス、軟膏、パック、ハップ剤、皮膚洗浄剤(石鹸類など)、洗顔料、シャンプー、リンス、トリートメント、各種メークアップ化粧料、浴剤など、多様なものとすることができる。 The application site of cosmetics (including quasi-drugs) containing the composition of the present invention includes general skin including the scalp, and is not particularly limited. Therefore, the dosage forms include emulsions, creams, lotions, essences, ointments, packs, haps, skin cleansers (soaps, etc.), facial cleansers, shampoos, rinses, treatments, various makeup cosmetics, bath preparations, etc. It can be diverse.
次に、製造例、処方例、実施例及び試験例によって本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。なお、以下において、部はすべて重量部を、また%はすべて重量%を意味する。 Next, the present invention will be described more specifically with reference to production examples, formulation examples, examples, and test examples, but the present invention is not limited thereto. In the following, all parts are parts by weight, and all percentages are% by weight.
製造例1.米抽出物
精白米1000gに0.025M水酸化ナトリウム溶液1250gを加え室温で、21時間攪拌した。ろ過によって固形物を除去し、抽出液をpH7.5に調製して、米抽出液750gを得た(固形分濃度2.1%)。
Production Example 1 Rice extract 1250 g of 0.025M sodium hydroxide solution was added to 1000 g of polished rice and stirred at room temperature for 21 hours. Solid matter was removed by filtration, and the extract was adjusted to pH 7.5 to obtain 750 g of rice extract (solid content concentration 2.1%).
製造例2.米抽出物の加水分解物
精白米1000gに0.025M水酸化ナトリウム溶液1250gを加え室温で、21時間攪拌した。ろ過によって固形物を除去し、抽出液をpH7.5に調製した。この抽出液にパパイン0.02%及びアクチナーゼ0.02%を加えて40℃2時間加水分解を行った。酵素を加熱失活した後、この液をろ過して米抽出物加水分解液600gを得た(固形分濃度1.8%)。
Production Example 2 Hydrolyzate of rice extract 1250 g of 0.025M sodium hydroxide solution was added to 1000 g of polished white rice and stirred at room temperature for 21 hours. Solids were removed by filtration and the extract was adjusted to pH 7.5. Papain 0.02% and actinase 0.02% were added to this extract, and hydrolysis was performed at 40 ° C. for 2 hours. After the enzyme was inactivated by heating, this solution was filtered to obtain 600 g of a rice extract hydrolyzate (solid content concentration 1.8%).
製造例3.米発酵物
精白米100gを水洗し、精製水900gを加えて懸濁液を調製し、加熱殺菌した。この液にグルコアミラーゼ1.0g、パパイン1.0gを加えた後、乳酸菌(ラクトバシルス
プランタラム)を108個/mL接種し、37℃で3日間静置培養した。培養終了後、培養液を加熱殺菌し、室温まで冷却して米の発酵物を得た(固形分濃度2.5重量%)。
Production Example 3 100 g of fermented rice polished rice was washed with water, 900 g of purified water was added to prepare a suspension, and heat sterilized. After adding 1.0 g of glucoamylase and 1.0 g of papain to this solution, 10 8 cells / mL of lactic acid bacteria (Lactobacils plantarum) were inoculated, and statically cultured at 37 ° C. for 3 days. After completion of the culture, the culture solution was sterilized by heating and cooled to room temperature to obtain a fermented rice product (solid content concentration 2.5% by weight).
製造例4.白芥子の抽出物
白芥子の種子の粉砕物100gと精製水1000gとを混合してpHを約5に調整し、室温下で24時間抽出したのち、これをろ過して抽出液(固形分濃度:約1.1重量%)を得た。
Production Example 4 White coconut extract 100 g of white coconut seed pulverized product and 1000 g of purified water were mixed to adjust the pH to about 5 and extracted at room temperature for 24 hours. : About 1.1% by weight).
製造例5.白芥子の酵素分解物
白芥の種子(白芥子)の粉砕物50gに精製水1000gを混合し、40℃で1時間抽出を行った後ろ過し、淡黄色透明の白芥子抽出物溶液805g(固形分濃度:1.2重量%)を得た。次に、ここに得られた抽出物溶液500gに、アクチナーゼAS(科研ファルマ株式会社製)を0.05g添加し、40℃で2時間加水分解した。その後、85℃で1時間加熱して酵素を失活させた後ろ過し、淡黄色透明の白芥子抽出物の加水分解物溶液460g(固形分濃度1.0重量%)を得た。
Production Example 5 Enzyme-decomposed product of white coconut 50 g of crushed white birch seeds (white coconut) was mixed with 1000 g of purified water, extracted at 40 ° C. for 1 hour, filtered and 805 g of a pale yellow transparent white coconut extract solution ( Solid concentration: 1.2% by weight) was obtained. Next, 0.05 g of actinase AS (manufactured by Kaken Pharma Co., Ltd.) was added to 500 g of the extract solution obtained here, and hydrolyzed at 40 ° C. for 2 hours. Thereafter, the enzyme was inactivated by heating at 85 ° C. for 1 hour, followed by filtration to obtain 460 g (solid content concentration: 1.0% by weight) of a hydrolyzate solution of a pale yellow transparent white coconut extract.
製造例6.白芥子の発酵物
白芥の種子(白芥子)100gを粉砕し、これに精製水900gを加えて懸濁液を調製した。この懸濁液に蛋白分解酵素(アクチナーゼAS;科研ファルマ株式会社製)0.1gを加えて40℃で2時間加水分解した後、80℃で1時間抽出並びに酵素失活処理を行い、室温まで冷却後ろ過して白芥子の抽出物溶液を得た。次に、この液を加熱殺菌し、乳酸菌(ラクトバシルス
プランタラム)を108個/mL接種し、37℃で3日間静置培養した。培養終了後培養液を加熱殺菌し、室温まで冷却後ろ過して白芥子の乳酸菌発酵物溶液658g(固形分濃度2.2%)を得た。
Production Example 6 Fermented white cocoon 100 g of white birch seed (white coconut) was pulverized, and 900 g of purified water was added thereto to prepare a suspension. After adding 0.1 g of proteolytic enzyme (actinase AS; manufactured by Kaken Pharma Co., Ltd.) to this suspension and hydrolyzing at 40 ° C. for 2 hours, extraction and enzyme deactivation treatment were performed at 80 ° C. for 1 hour. After cooling, filtration was performed to obtain a white coconut extract solution. Next, this liquid was sterilized by heating, inoculated with 10 8 cells / mL of lactic acid bacteria (Lactobacillus plantarum), and cultured at 37 ° C. for 3 days. After completion of the culture, the culture broth was sterilized by heating, cooled to room temperature and filtered to obtain 658 g of a white lactic acid bacterium fermentation product solution (solid content concentration 2.2%).
製造例7.ハスの種子の抽出物
ハスの種子(渋皮を除去したもの)100gを粉砕し、精製水1900gを加えて懸濁液を調製し、80℃で2時間加熱した。この液をろ過して、ハス種子抽出物溶液1360g(固形分濃度0.9%)を得た。
Production Example 7 Extract of lotus seeds 100 g of lotus seeds (those with astringent skin removed) were pulverized, and 1900 g of purified water was added to prepare a suspension, which was heated at 80 ° C. for 2 hours. This solution was filtered to obtain 1360 g of a lotus seed extract solution (solid content concentration: 0.9%).
製造例8.ハスの種子の加水分解物
ハスの種子(渋皮を除去したもの)100gを粉砕し、精製水1900gを加えて懸濁液を調製し、加熱殺菌した。この液にグルコアミラーゼ1g、パパイン1g及びセルラーゼ0.5gを加えた後、を加えた後、pHを7.5に調整し、45℃に15時間保持した。この液をろ過して、ハス種子の加水分解溶液1400g(固形分濃度1.9%)を得た。
Production Example 8 Lotus seed hydrolyzate 100 g of lotus seed (with the astringent skin removed) was crushed, 1900 g of purified water was added to prepare a suspension, and heat sterilized. After adding 1 g of glucoamylase, 1 g of papain and 0.5 g of cellulase to this solution, pH was adjusted to 7.5 after being added and kept at 45 ° C. for 15 hours. This solution was filtered to obtain 1400 g of a lotus seed hydrolyzed solution (solid content concentration 1.9%).
製造例9.ハスの種子の発酵物
ハスの種子(渋皮を除去したもの)100gを粉砕し、精製水1900gを加えて懸濁液を調製し、加熱殺菌した。この懸濁液にグルコアミラーゼ1g、パパイン1g及びセルラーゼ0.5gを加えた後、乳酸菌(ラクトバチルス
プランタラム)を108個/mL接種し、窒素気流下に37℃で3日間静置培養した。培養終了後加熱殺菌し、培養液をろ過して、ハス種子の乳酸菌発酵物溶液1460g(固形分濃度3.0%)を得た。
Production Example 9 A lotus seed fermented lotus seed (with astringent skin removed) 100 g was crushed, 1900 g of purified water was added to prepare a suspension, and heat sterilized. After adding 1 g of glucoamylase, 1 g of papain and 0.5 g of cellulase to this suspension, 10 8 cells / mL of lactic acid bacteria (Lactobacillus plantarum) were inoculated, followed by static culture at 37 ° C. for 3 days under a nitrogen stream. . After completion of the culture, the mixture was sterilized by heating, and the culture solution was filtered to obtain 1460 g of a lotus seed lactic acid bacteria fermented solution (solid content concentration: 3.0%).
製造例10.ハトムギの種子の抽出物
殻を除いたハトムギ種子50gを粉砕し、精製水950gを加えて懸濁液を調製し、80℃で2時間加熱した。この液をろ過して、ハトムギ種子抽出物溶液770g(固形分濃度2.1%)を得た。
Production Example 10 50 g of barley seeds excluding the husk seed extract shell were pulverized, 950 g of purified water was added to prepare a suspension, and the mixture was heated at 80 ° C. for 2 hours. This solution was filtered to obtain 770 g of a barley seed extract solution (solid content concentration 2.1%).
製造例11.ハトムギの種子の加水分解物
殻を除いたハトムギ種子50gを粉砕し、精製水950gを加えて懸濁液を調製し、80℃で2時間加熱した。この液にグルコアミラーゼ0.5g、パパイン0.5gを加えた得た後、37℃で酵素か分解処理を行った。冷却後、この液をろ過して、ハトムギ種子加水分解物溶液765g(固形分濃度2.2%)を得た。
Production Example 11 50 g of barley seeds excluding the hydrolyzed shell of pearl barley were pulverized and 950 g of purified water was added to prepare a suspension, which was heated at 80 ° C. for 2 hours. After adding 0.5 g of glucoamylase and 0.5 g of papain to this solution, the enzyme was digested at 37 ° C. After cooling, this solution was filtered to obtain 765 g of pearl seed hydrolyzate solution (solid content concentration 2.2%).
製造例12.ハトムギ種子の発酵物
殻を除いたハトムギ種子50gを粉砕し、精製水950gを加えて懸濁液を調製し、加熱殺菌をした。この懸濁液にグルコアミラーゼ0.5g、パパイン0.5gを加えた得た後、酵母(サッカロミセス セレビシエ)を107個/mL接種し、37℃で3日間静置培養した。培養数量後、加熱殺菌し、室温まで冷却後、ろ過してハトムギ種子発酵物溶液500gを得た(固形分濃度1.3%)。
Production Example 12. 50 g of barley seeds excluding the fermented husk of barley seeds were pulverized, 950 g of purified water was added to prepare a suspension, and heat sterilized. After adding 0.5 g of glucoamylase and 0.5 g of papain to this suspension, 10 7 yeast / mL of yeast (Saccharomyces cerevisiae) was inoculated and left to stand at 37 ° C. for 3 days. After the number of cultures, the mixture was sterilized by heating, cooled to room temperature, and filtered to obtain 500 g of pearl seed fermented product solution (solid content concentration 1.3%).
下記表1、2に示すように、上記製造例1〜12の抽出物、加水分解物及び発酵物のうちのいずれか3種以上を含む実施例1〜37の化粧料組成物、さらに、当該組成物に上述した美白剤、抗酸化剤、抗炎症剤、又は血行促進剤のいずれか1種以上を加えた実施例38〜49の化粧料組成物を調製した。また、後述する有効性の比較対照として、製造例1の米抽出物のみからなる組成物(比較実施例1)を調製した。 As shown in Tables 1 and 2 below, the cosmetic compositions of Examples 1 to 37 containing any three or more of the extracts, hydrolysates and fermented products of Production Examples 1 to 12, and The cosmetic compositions of Examples 38 to 49 were prepared by adding any one or more of the above-described whitening agents, antioxidants, anti-inflammatory agents, and blood circulation promoters to the compositions. Moreover, the composition (comparative example 1) which consists only of the rice extract of manufacture example 1 was prepared as a comparative comparison of the effectiveness mentioned later.
[表1]
[Table 1]
[表2]
[Table 2]
[表3]
[Table 3]
[表4]
[Table 4]
以下に、本発明の好ましい処方例を示す。
処方例1.乳液
[A成分] 部
流動パラフィン 6.0
ヘキサラン 4.0
ホホバ油 1.0
ポリオキシエチレン(20)ソルビタンモノステアレート 2.0
大豆レシチン 1.5
メチルパラベン 0.15
エチルパラベン 0.03
[B成分]
実施例1の組成物 3.0(本処方例1の乳液100部に対する組成物の重量%)
L−アスコルビン酸−2−グルコシド 2.0
水酸化カリウム 0.5
豆乳乳酸菌発酵エキス 1.0
グリセリン 3.0
1、3−ブチレングリコール 2.0
カルボキシメチルセルロース 0.3
ヒアルロン酸ナトリウム 0.01
精製水 全量が100部となる量
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。これを50℃まで冷却した後、C成分を加えてさらに攪拌混合して乳液を得た。
Below, the preferable formulation example of this invention is shown.
Formulation Example 1 Latex [Component A] Liquid paraffin 6.0
Hexalan 4.0
Jojoba oil 1.0
Polyoxyethylene (20) sorbitan monostearate 2.0
Soy lecithin 1.5
Methylparaben 0.15
Ethylparaben 0.03
[B component]
Composition of Example 1 3.0 (% by weight of composition with respect to 100 parts of emulsion of Formulation Example 1)
L-ascorbic acid-2-glucoside 2.0
Potassium hydroxide 0.5
Soy milk lactic acid bacteria fermentation extract 1.0
Glycerin 3.0
1,3-butylene glycol 2.0
Carboxymethylcellulose 0.3
Sodium hyaluronate 0.01
Amount of purified water totaling 100 parts
[C component]
Perfume
The components A and B were each heated to 80 ° C. or higher and then mixed by stirring. After cooling this to 50 ° C., component C was added and further stirred and mixed to obtain an emulsion.
処方例2〜28.乳液
処方例1のB成分中、実施例1の組成物に代えて実施例2〜28のうちのいずれか1つの組成物3.0部を用いるほかは処方例1と同様にして乳液を得た。
Formulation Examples 2-28. Emulsion An emulsion is obtained in the same manner as in Formulation Example 1 except that 3.0 parts of any one of Examples 2 to 28 is used in place of the composition of Example 1 in Component B of Formulation Example 1. It was.
処方例29〜37.乳液
処方例1のB成分中、実施例1の組成物に代えて実施例29〜37のうちのいずれか1つの組成物4.0部を用いるほかは処方例1と同様にして乳液を得た。
Formulation Examples 29-37. Emulsion An emulsion was obtained in the same manner as in Formulation Example 1 except that 4.0 parts of any one of Examples 29 to 37 were used in place of the composition of Example 1 in Component B of Formulation Example 1. It was.
処方例38〜49.乳液
処方例1のB成分中、実施例1の組成物に代えて実施例38〜49のうちのいずれか1つの組成物5.0部を用いるほかは処方例1と同様にして乳液を得た。
Formulation examples 38-49. Emulsion In the component B of Formulation Example 1, an emulsion was obtained in the same manner as Formulation Example 1 except that 5.0 parts of any one of Examples 38 to 49 were used instead of the composition of Example 1. It was.
処方例50.ローション
[A成分] 部
実施例1の組成物 3.0(本処方例50のローション100部に対する組成物の重量%)
エタノール 10.0
グリセリン 3.0
1,3−ブチレングリコール 2.0
メチルパラベン 0.2
クエン酸 0.1
クエン酸ナトリウム 0.3
カルボキシビニルポリマー 0.1
香料 適量
水酸化カリウム 適量
精製水 全量が100部となる量
上記の成分を混合してローションを得た。
Formulation Example 50. Lotion [Component A] Part Composition of Example 1 3.0 (% by weight of composition with respect to 100 parts of Lotion of Formulation Example 50)
Ethanol 10.0
Glycerin 3.0
1,3-butylene glycol 2.0
Methylparaben 0.2
Citric acid 0.1
Sodium citrate 0.3
Carboxyvinyl polymer 0.1
Fragrance Appropriate amount Potassium hydroxide Appropriate amount Purified water An amount that makes the total amount 100 parts.
処方例51〜77.ローション
処方例50のA成分中、実施例1の組成物に代えて実施例2〜28のうちのいずれか1つの組成物3.0部を用いるほかは処方例50と同様にしてローションを得た。
Formulation Examples 51-77. Lotion A lotion was obtained in the same manner as in Formulation Example 50 except that 3.0 parts of any one of Examples 2 to 28 was used instead of the composition of Example 1 in component A of Formulation Example 50. It was.
処方例78〜86.ローション
処方例50のA成分中、実施例1の組成物に代えて実施例29〜37のうちのいずれか1つの組成物4.0部を用いるほかは処方例50と同様にしてローションを得た。
Formulation examples 78-86. Lotion A lotion was obtained in the same manner as in Formulation Example 50 except that 4.0 parts of any one of Examples 29 to 37 was used instead of the composition of Example 1 in component A of Formulation Example 50. It was.
処方例87〜98.ローション
処方例50のB成分中、実施例1の組成物に代えて実施例38〜49のうちのいずれか1つの組成物5.0部を用いるほかは処方例50と同様にしてローションを得た。
Formulation examples 87-98. Lotion A lotion was obtained in the same manner as in Formulation Example 50 except that 5.0 parts of any one of Examples 38 to 49 were used instead of the composition in Example 1 in the B component of Formulation Example 50. It was.
処方例99.化粧水
[A成分] 部
オリーブ油 1.0
ポリオキシエチレン(5.5)セチルアルコール 5.0
ブチルパラベン 0.1
[B成分]
実施例1の組成物 3.0(本処方例100の化粧水100部に対する組成物の重量%)
エタノール 5.0
グリセリン 5.0
1,3−ブチレングリコール 5.0
メチルパラベン 0.1
水酸化カリウム 適量
精製水 全量が100部となる量
[C成分]
香料 適量
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して化粧水を得た。
Formulation Example 99. Lotion [A component] part olive oil 1.0
Polyoxyethylene (5.5) cetyl alcohol 5.0
Butylparaben 0.1
[B component]
Composition of Example 1 3.0 (% by weight of the composition based on 100 parts of the lotion of the present Formulation Example 100)
Ethanol 5.0
Glycerin 5.0
1,3-butylene glycol 5.0
Methylparaben 0.1
Potassium hydroxide appropriate amount Purified water Amount that makes 100 parts in total
[C component]
Perfume
After each component A and component B was heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes. After cooling this to 50 degreeC, C component was added and stirred and mixed, and also it cooled to 30 degrees C or less, and the lotion was obtained.
処方例100〜126.化粧水
処方例99のB成分中、実施例1の組成物に代えて実施例2〜28のいずれか1つの組成物3.0部を用いるほかは処方例99と同様にして化粧水を得た。
Formulation examples 100-126. Lotion Toner lotion is obtained in the same manner as in Formulation Example 99, except that 3.0 parts of any one of Examples 2 to 28 is used in place of the composition of Example 1 in Component B of Formulation Example 99. It was.
処方例127〜135.化粧水
処方例99のB成分中、実施例1の組成物に代えて実施例29〜37のいずれか1つの組成物4.0部を用いるほかは処方例99と同様にして化粧水を得た。
Formulation examples 127-135. Lotion Toner lotion is obtained in the same manner as in Formulation Example 99 except that 4.0 parts of any one of Examples 29 to 37 are used in the component B of Formulation Example 99 instead of the composition of Example 1. It was.
処方例136〜147.化粧水
処方例100のB成分中、実施例1の組成物に代えて実施例38〜49のいずれか1つの組成物5.0部を用いるほかは処方例100と同様にして化粧水を得た。
Formulation examples 136-147. Lotion Toner lotion is obtained in the same manner as in Formulation Example 100 except that 5.0 parts of any one of Examples 38 to 49 are used in Component B of Formulation Example 100 instead of the composition of Example 1. It was.
処方例148.乳液
処方例1のB成分中、L−アスコルビン酸−2−グルコシド2.0部に代えてL−アスコルビン酸−2−グルコシド1.0部及びアルブチン1.0部を用いるほかは処方例1と同様にして乳液を得た。
Formulation Example 148. In the component B of the emulsion formulation example 1, instead of using 2.0 parts of L-ascorbic acid-2-glucoside, 1.0 part of L-ascorbic acid-2-glucoside and 1.0 part of arbutin are used. An emulsion was obtained in the same manner.
処方例150.乳液
処方例1のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えてトラネキサム酸2.0部を用いるほかは処方例1と同様にして乳液を得た。
Formulation Example 150. Emulsion In the same manner as in Formulation Example 1, except that 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 parts of potassium hydroxide are used instead of 2.0 parts of L-ascorbic acid-2-glucoside. Got.
処方例151.乳液
処方例1のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えて米糠抽出物加水分解物(固形分濃度3.5%)5.0部を用いるほかは処方例1と同様にして乳液を得た。
Formulation Example 151. In the component B of the emulsion formulation example 1, in place of 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 parts of potassium hydroxide, rice bran extract hydrolyzate (solid content concentration: 3.5%) 5.0 A milky lotion was obtained in the same manner as in Formulation Example 1 with the exception of using the part.
試験例1.細胞内チロシナーゼ活性抑制作用
以下の実施例1〜49の組成物を試料として用いて各組成物のチロシナーゼ抑制効果及び線維芽細胞賦活効果について調べた。
[試験方法]
培養B16マウスメラノーマ細胞を、96穴マイクロプレートに8×103個/穴播種し、10%仔牛血清(FBS)含有イーグル最少必須培地(MEM)中、37℃、5%CO2の条件下に1日間プレ培養した後、10%FBS含有イーグルMEMに実施例1〜49の各組成物をそれぞれ試料溶液として添加し、同条件で2日間培養した。ここで、本試験で用いた各組成物の溶液としての終濃度は、実施例1〜28の各組成物であれば当該培地100部に対して3.0重量%となるように、又実施例29〜46の各組成物であれば、当該培地100部に対して4.0重量%となるように、又実施例47〜49の各組成物であれば5.0重量%となるように調製した。次に培養液を除去し、界面活性剤(Triton X-100)と5mMのL−ドーパ溶液を添加して37℃で反応を行った後、マイクロプレートリーダー(Model 450、バイオラッド社製)を用い、波長490nmでドーパ値を測定した。試料無添加の場合(対照)についても上記と同様の操作を行い、ここに得られたドーパ値に対する各試料添加時のドーパ値の相対値を求め、チロシナーゼ活性率(%)とした。なお、比較のため、試料溶液の代わりに、3mMのアルブチンを添加した場合(陽性対照)についても同様の試験を行った。なお、比較対照として、製造例1の米抽出物のみからなる比較試料1(培地100部に対して溶液としての終濃度が3.0重量%)についても、同様の試験を行った。
Test Example 1 Inhibition of intracellular tyrosinase activity Using the compositions of Examples 1 to 49 below as samples, the tyrosinase inhibitory effect and fibroblast activation effect of each composition were examined.
[Test method]
Cultured B16 mouse melanoma cells were seeded at 8 × 10 3 cells / well in a 96-well microplate and placed in Eagle's minimum essential medium (MEM) containing 10% calf serum (FBS) under conditions of 37 ° C. and 5% CO 2 . After pre-culturing for 1 day, each composition of Examples 1 to 49 was added as a sample solution to Eagle MEM containing 10% FBS and cultured for 2 days under the same conditions. Here, the final concentration of each composition used in this test as a solution was 3.0% by weight with respect to 100 parts of the culture medium for each composition of Examples 1-28. If it is each composition of Examples 29-46, it will be 4.0 weight% with respect to 100 parts of the said culture medium, and if it is each composition of Examples 47-49, it will be 5.0 weight%. Prepared. Next, the culture solution is removed, and a surfactant (Triton X-100) and 5 mM L-dopa solution are added and reacted at 37 ° C. Then, a microplate reader (Model 450, manufactured by Bio-Rad) is used. The dopa value was measured at a wavelength of 490 nm. In the case of no sample addition (control), the same operation as described above was performed, and the relative value of the dopa value at the time of each sample addition with respect to the obtained dopa value was determined and used as the tyrosinase activity rate (%). For comparison, the same test was performed when 3 mM arbutin was added instead of the sample solution (positive control). In addition, the same test was done also about the comparative sample 1 (The final concentration as a solution is 3.0 weight% with respect to 100 parts of culture media) which consists only of the rice extract of manufacture example 1 as a comparison control.
試験例2.線維芽細胞賦活効果
[試験方法]
ヒト真皮由来線維芽細胞を、0.5%FCS含有最少必須培地を入れた96穴マイクロプレートに1×104個/穴播種し、37℃で1日間プレ培養した後、実施例1〜49の各組成物をそれぞれ試料溶液として添加し、37℃でさらに6日間培養した。ここで、本試験で用いた各組成物の溶液としての終濃度は、実施例1〜28の各組成物であれば当該培地100部に対して3.0重量%となるように、又実施例29〜46の各組成物であれば、当該培地100部に対して4.0重量%となるように、又実施例47〜49の各組成物であれば5.0重量%となるように調製した。次に、培地を除去し界面活性剤(TRITON X-100)を添加した細胞処理液に、0.2%のMTTを添加して37℃に保持した後、マイクロプレートリーダー(Model1450、バイオラッド社製)を用い、波長370−530nmでMTT値を測定した。試料無添加の場合(対照)についても上記と同様の操作を行い、ここに得られたMTT値に対する各試料添加時のMTT値の相対値を求め、線維芽細胞MTT活性率(%)とした。なお比較のため、試料溶液の代わりにグルコースを50mM添加した場合(陽性対照)についても、同様の試験を行った。さらに、比較対照として、製造例1の米抽出物のみからなる比較試料1(培地100部に対して溶液としての終濃度が3.0重量%)についても、同様の試験を行った。
Test Example 2 Fibroblast activation effect [Test method]
Human dermis-derived fibroblasts were seeded at 1 × 10 4 cells / hole in a 96-well microplate containing 0.5% FCS-containing minimum essential medium, pre-cultured at 37 ° C. for 1 day, and then Examples 1-49 Each composition was added as a sample solution and cultured at 37 ° C. for another 6 days. Here, the final concentration of each composition used in this test as a solution was 3.0% by weight with respect to 100 parts of the culture medium for each composition of Examples 1-28. If it is each composition of Examples 29-46, it will be 4.0 weight% with respect to 100 parts of the said culture medium, and if it is each composition of Examples 47-49, it will be 5.0 weight%. Prepared. Next, 0.2% MTT was added to the cell treatment solution to which the medium was removed and the surfactant (TRITON X-100) was added, and the mixture was kept at 37 ° C., and then a microplate reader (Model 1450, Bio-Rad). MTT value was measured at a wavelength of 370 to 530 nm. In the case where no sample was added (control), the same operation as described above was performed, and the relative value of the MTT value at the time of adding each sample to the MTT value obtained here was determined to obtain the fibroblast MTT activity rate (%). . For comparison, the same test was performed when 50 mM glucose was added instead of the sample solution (positive control). Further, as a comparative control, the same test was performed on Comparative Sample 1 (only the concentration of 3.0% by weight as a solution with respect to 100 parts of the medium) consisting only of the rice extract of Production Example 1.
実施例1〜49の各組成物の細胞内チロシナーゼ活性効果及び線維芽細胞賦活効果の試験結果について、表5,6に示す。 Tables 5 and 6 show the test results of the intracellular tyrosinase activity effect and the fibroblast activation effect of each composition of Examples 1 to 49.
[表5]
[Table 5]
[表6]
[Table 6]
以上のように、実施例1〜49の組成物のいずれも、比較試料1と比較して格段にすぐれた細胞内チロシナーゼ活性抑制効果、及び線維芽細胞賦活効果を示すことが確認されたことから、これらの組成物は、皮膚細胞に損傷を与えることなく、すぐれた美白及び美肌効果を発揮することが明らかとなった。なお、陽性対照のアルブチン及びグルコースも細胞内チロシナーゼ活性抑制効果、及び線維芽細胞賦活効果を示したことから、本試験系が正常に行われていることも確認された。 As described above, it was confirmed that any of the compositions of Examples 1 to 49 exhibited markedly superior intracellular tyrosinase activity inhibitory effect and fibroblast activation effect as compared with Comparative Sample 1. These compositions have been shown to exhibit excellent whitening and skin beautifying effects without damaging skin cells. In addition, since the positive controls arbutin and glucose also showed the intracellular tyrosinase activity inhibitory effect and the fibroblast activation effect, it was also confirmed that this test system was performed normally.
試験例3.パネルテスト(肌のハリ、ツヤ、くすみ、シミ、ソバカス、小ジワ、使用感)
本発明の化粧料組成物を配合した化粧料(乳液)に関して、肌のハリ、ツヤ、くすみ、シミ、ソバカス、小ジワ及び使用感を、モニターによる実使用テストで評価した。
Test Example 3 Panel test (skin elasticity, gloss, dullness, spots, freckles, wrinkles, feeling of use)
Regarding cosmetics (milky lotion) containing the cosmetic composition of the present invention, skin firmness, luster, dullness, spots, freckles, wrinkles and feeling of use were evaluated by an actual use test using a monitor.
[試料]
本試験例3においては、下記のエッセンスを試料とした。
(1)本発明試料1
[成分] 部
エタノール 2.0
グリセリン 5.0
1,3−ブチレングリコール 5.0
メチルパラベン 0.1
実施例3の組成物 3.0
クエン酸 0.3
クエン酸ナトリウム 0.6
精製水 全量が100部となる量
(2)本発明試料2.
上記本発明試料1に於いて実施例1の組成物に代えて、実施例6の組成物を配合したエッセンス。
(3)本発明試料3.
上記本発明試料1に於いて実施例1の組成物に代えて、実施例11の組成物を配合したエッセンス。
(4)本発明試料4.
上記本発明試料1に於いて実施例1の組成物に代えて、実施例20の組成物を配合したエッセンス。
(5)本発明試料5.
上記本発明試料1に於いて実施例1の組成物に代えて、実施例31の組成物を配合したエッセンス。
(6)本発明試料6.
上記本発明試料1に於いて実施例1の組成物に代えて、実施例49の組成物を配合したエッセンス。
(7)比較試料1.
上記本発明試料1に於いて実施例1の組成物に代えて、比較実施例1の組成物を配合したエッセンス。
[試験方法]
無作為に抽出した年齢18〜50歳の女性120名を被験者として、本発明試料1〜6のいずれか1つと、比較試料1とを、それぞれ左右の頬部に、本発明例又は比較例の乳液を1日2回(朝、晩)、1ヵ月間塗布してもらった時の使用感及び肌の状態を、下記の1〜4の項目毎に評価した。肌のハリ,ツヤ、くすみ、シミ,ソバカスについては、A:改善された、B:やや改善された、C:変わらない、D:やや悪くなった、E:悪くなった、という5段階評価によってそれぞれ行った。また、使用感は、手に取った感触、塗布時の伸び、塗布時のなめらかさ、及び塗布後の感触に基づいて、A:非常に良い、B:良い、C:普通、D:やや悪い、E:悪い、という5段階評価によって、それぞれ行った。
[sample]
In Test Example 3, the following essence was used as a sample.
(1) Invention sample 1
[Ingredients] part ethanol 2.0
Glycerin 5.0
1,3-butylene glycol 5.0
Methylparaben 0.1
Composition of Example 3 3.0
Citric acid 0.3
Sodium citrate 0.6
2. Amount of purified water to 100 parts (2) Sample of the present invention
The essence which mix | blended the composition of Example 6 instead of the composition of Example 1 in the said this invention sample 1. FIG.
(3) Invention sample 3.
The essence which mix | blended the composition of Example 11 in the said invention sample 1 instead of the composition of Example 1. FIG.
(4) Invention sample 4.
The essence which mix | blended the composition of Example 20 instead of the composition of Example 1 in the said this invention sample 1. FIG.
(5) Invention sample 5.
The essence which mix | blended the composition of Example 31 instead of the composition of Example 1 in the said this invention sample 1. FIG.
(6) Sample of the present invention
The essence which mix | blended the composition of Example 49 instead of the composition of Example 1 in the said this invention sample 1. FIG.
(7) Comparative sample
The essence which mix | blended the composition of the comparative example 1 instead of the composition of the example 1 in the said this invention sample 1. FIG.
[Test method]
Using 120 women aged 18 to 50 randomly extracted as subjects, any one of the inventive samples 1 to 6 and the comparative sample 1 were placed on the left and right cheeks respectively of the inventive example or the comparative example. When the emulsion was applied twice a day (morning and evening) for 1 month, the feeling of use and the skin condition were evaluated for each of the following items 1 to 4. For skin firmness, gloss, dullness, spots, and freckles, A: improved, B: slightly improved, C: unchanged, D: slightly worsened, E: slightly worsened, E: worsened Each went. In addition, the feeling of use is A: very good, B: good, C: normal, and D: slightly bad based on the feeling taken by the hand, the elongation during application, the smoothness during application, and the feeling after application. , E: Each was performed by a five-step evaluation of bad.
[結果]
評価結果を表7に示す。
[表7]
以上のように、本発明試料1〜6は、いずれも比較試料1と比較して、肌のハリ,ツヤ、くすみ、シミ,ソバカス、小ジワの改善の実感効果が高かった。さらに、本発明試料1〜6は、使用感の実感効果も比較試料1と比較して高かった。
[result]
Table 7 shows the evaluation results.
[Table 7]
As described above, each of the inventive samples 1 to 6 had a higher effect of improving skin firmness, gloss, dullness, spots, freckles, and fine wrinkles as compared with Comparative Sample 1. Furthermore, the inventive samples 1 to 6 also had a higher feeling of use feeling than the comparative sample 1.
以上の結果から、本発明の組成物は、それら組成物に含まれる米、アブラナ科ブラシカ属の植物、スイレン科ハス属の植物、及びハトムギのうちの3種以上の植物の成分に基づく格段にすぐれた美白及び美肌効果を発揮し、かつ、使用感にすぐれていることから、肌のハリ、ツヤ、くすみ、シミ、ソバカス、小ジワの改善用の化粧料の配合成分として有用である。
From the above results, the composition of the present invention is remarkably based on the components of three or more kinds of plants among the rice, Brassicaceae Brassica genus, Lilyaceae lotus genus, and pearl barley included in these compositions. Since it exhibits excellent whitening and skin-beautifying effects and is excellent in use feeling, it is useful as a compounding ingredient for cosmetics for improving skin firmness, gloss, dullness, spots, freckles, and fine wrinkles.
Claims (2)
上記植物の成分は当該植物の抽出物又は当該抽出物の加水分解物、或いは当該植物の発酵物であることを特徴とする化粧料。 A cosmetic comprising three or more plant components of rice, Brassica plant, Nympaeaceae lotus (Nelumbo) plant and pearl barley,
The plant component is an extract of the plant, a hydrolyzate of the extract, or a fermented product of the plant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012257782A JP6474186B2 (en) | 2012-11-26 | 2012-11-26 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012257782A JP6474186B2 (en) | 2012-11-26 | 2012-11-26 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014105167A true JP2014105167A (en) | 2014-06-09 |
JP6474186B2 JP6474186B2 (en) | 2019-02-27 |
Family
ID=51026963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012257782A Active JP6474186B2 (en) | 2012-11-26 | 2012-11-26 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6474186B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014144920A (en) * | 2013-01-25 | 2014-08-14 | Tekunooburu:Kk | External composition for skin |
JP2020090544A (en) * | 2016-05-10 | 2020-06-11 | 丸善製薬株式会社 | Cosmetics and food and drink composition |
JP2021004214A (en) * | 2019-06-27 | 2021-01-14 | 株式会社再春館製薬所 | Combinational fermented product |
JP7330489B2 (en) | 2019-05-14 | 2023-08-22 | 共栄化学工業株式会社 | Skin topical agent |
JP7460998B2 (en) | 2017-05-18 | 2024-04-03 | 共栄化学工業株式会社 | Skin preparations |
Citations (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS521042A (en) * | 1975-06-24 | 1977-01-06 | Koichi Ogawa | Toilet good |
JPS60258104A (en) * | 1984-06-06 | 1985-12-20 | Inahata Koryo Kk | Cosmetic composition having moisture retention |
JPS6256410A (en) * | 1985-09-06 | 1987-03-12 | Soken:Kk | Production of cosmetic and bathing agent from aloe, mugwort and adlay |
JPH04117318A (en) * | 1990-09-06 | 1992-04-17 | Soken:Kk | Cutaneous amelioration agent |
JPH04247012A (en) * | 1991-02-04 | 1992-09-03 | Mikimoto Pharmaceut Co Ltd | Cosmetic |
JPH05221844A (en) * | 1992-02-17 | 1993-08-31 | Kyoei Kagaku Kogyo Kk | Aging-preventive cosmetic |
JPH06192061A (en) * | 1991-12-10 | 1994-07-12 | Soken Kk | Cosmetic |
JPH0710733A (en) * | 1993-06-18 | 1995-01-13 | Soken Kk | Cosmetic made from rice |
JPH08325130A (en) * | 1995-05-29 | 1996-12-10 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JPH11279069A (en) * | 1998-03-27 | 1999-10-12 | Ichimaru Pharcos Co Ltd | Active oxygen eliminating agent |
JP2001089355A (en) * | 1999-09-22 | 2001-04-03 | Tokushima Seiko Kk | Cosmetic component comprising rice koji, dried koji and dried powdery koji, and its preparation method |
JP2001122757A (en) * | 1999-10-22 | 2001-05-08 | Naris Cosmetics Co Ltd | Active oxygen scavenger, antioxidant and cosmetic |
JP2001322940A (en) * | 2000-05-12 | 2001-11-20 | Kao Corp | Cathepsin d production facilitative agent |
JP2002068993A (en) * | 2000-08-30 | 2002-03-08 | Maruzen Pharmaceut Co Ltd | Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic |
JP2002370998A (en) * | 1998-09-30 | 2002-12-24 | Kao Corp | Ceramide production promoter |
JP2003081848A (en) * | 2001-09-13 | 2003-03-19 | Maruzen Pharmaceut Co Ltd | Active oxygen-eliminating agent, and cosmetic and food and drink containing the formulated active oxygen- eliminating agent |
JP2003238429A (en) * | 2002-02-12 | 2003-08-27 | Kyoei Kagaku Kogyo Kk | Fibroblast cell-activating agent and skin external agent containing the same |
JP2004010526A (en) * | 2002-06-06 | 2004-01-15 | Kose Corp | Skin care preparation for external use |
JP2005008539A (en) * | 2003-06-17 | 2005-01-13 | Fancl Corp | Matrix metalloproteinase inhibitor |
JP2005015450A (en) * | 2003-06-30 | 2005-01-20 | Kanebo Cosmetics Inc | Skin cosmetic |
JP2005047860A (en) * | 2003-07-30 | 2005-02-24 | Intaafueesu:Kk | Beautiful skin enhancer |
JP2005112780A (en) * | 2003-10-07 | 2005-04-28 | Kyoei Kagaku Kogyo Kk | Antioxidant and cosmetic containing the same |
JP2005154375A (en) * | 2003-11-27 | 2005-06-16 | Kyoei Kagaku Kogyo Kk | Skin lotion |
JP2005521649A (en) * | 2002-01-15 | 2005-07-21 | コグニス・フランス・ソシエテ・アノニム | Active substances for use in cosmetic and / or pharmaceutical products obtained by fermentation of plant components and / or plant extracts |
JP2005255613A (en) * | 2004-03-11 | 2005-09-22 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2005298489A (en) * | 2004-03-15 | 2005-10-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2005320308A (en) * | 2004-05-11 | 2005-11-17 | Kyoei Kagaku Kogyo Kk | Enzymic treated hydrolyzate and cosmetic comprising the same formulated therein |
JP2006045075A (en) * | 2004-08-02 | 2006-02-16 | Yukihiro Hirose | Composition having bleaching action and cosmetic containing the same |
JP2006104129A (en) * | 2004-10-06 | 2006-04-20 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2006111560A (en) * | 2004-10-14 | 2006-04-27 | Nippon Menaade Keshohin Kk | Ceramide synthesis promoter |
JP2006124350A (en) * | 2004-11-01 | 2006-05-18 | Nippon Menaade Keshohin Kk | Nmf production promoter |
JP2006296255A (en) * | 2005-04-19 | 2006-11-02 | Maruzen Pharmaceut Co Ltd | Enzymatic decomposition product of cereal, method for producing the same and functional article |
JP2007131578A (en) * | 2005-11-10 | 2007-05-31 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2007290998A (en) * | 2006-04-24 | 2007-11-08 | Morishita Jintan Kk | Sprouted adlay fermentation-treated product |
JP2008081491A (en) * | 2006-09-01 | 2008-04-10 | Kao Corp | External preparation for skin |
JP2010013414A (en) * | 2008-07-07 | 2010-01-21 | Toyo Shinyaku Co Ltd | Melanin formation suppressing agent |
JP2010138139A (en) * | 2008-12-15 | 2010-06-24 | Kyoei Kagaku Kogyo Kk | Skin-lightening agent and skin-lightening cosmetic |
JP2012056933A (en) * | 2010-09-13 | 2012-03-22 | Maruzen Pharmaceut Co Ltd | Elastin production promoter |
-
2012
- 2012-11-26 JP JP2012257782A patent/JP6474186B2/en active Active
Patent Citations (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS521042A (en) * | 1975-06-24 | 1977-01-06 | Koichi Ogawa | Toilet good |
JPS60258104A (en) * | 1984-06-06 | 1985-12-20 | Inahata Koryo Kk | Cosmetic composition having moisture retention |
JPS6256410A (en) * | 1985-09-06 | 1987-03-12 | Soken:Kk | Production of cosmetic and bathing agent from aloe, mugwort and adlay |
JPH04117318A (en) * | 1990-09-06 | 1992-04-17 | Soken:Kk | Cutaneous amelioration agent |
JPH04247012A (en) * | 1991-02-04 | 1992-09-03 | Mikimoto Pharmaceut Co Ltd | Cosmetic |
JPH06192061A (en) * | 1991-12-10 | 1994-07-12 | Soken Kk | Cosmetic |
JPH05221844A (en) * | 1992-02-17 | 1993-08-31 | Kyoei Kagaku Kogyo Kk | Aging-preventive cosmetic |
JPH0710733A (en) * | 1993-06-18 | 1995-01-13 | Soken Kk | Cosmetic made from rice |
JPH08325130A (en) * | 1995-05-29 | 1996-12-10 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JPH11279069A (en) * | 1998-03-27 | 1999-10-12 | Ichimaru Pharcos Co Ltd | Active oxygen eliminating agent |
JP2002370998A (en) * | 1998-09-30 | 2002-12-24 | Kao Corp | Ceramide production promoter |
JP2001089355A (en) * | 1999-09-22 | 2001-04-03 | Tokushima Seiko Kk | Cosmetic component comprising rice koji, dried koji and dried powdery koji, and its preparation method |
JP2001122757A (en) * | 1999-10-22 | 2001-05-08 | Naris Cosmetics Co Ltd | Active oxygen scavenger, antioxidant and cosmetic |
JP2001322940A (en) * | 2000-05-12 | 2001-11-20 | Kao Corp | Cathepsin d production facilitative agent |
JP2002068993A (en) * | 2000-08-30 | 2002-03-08 | Maruzen Pharmaceut Co Ltd | Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic |
JP2003081848A (en) * | 2001-09-13 | 2003-03-19 | Maruzen Pharmaceut Co Ltd | Active oxygen-eliminating agent, and cosmetic and food and drink containing the formulated active oxygen- eliminating agent |
JP2005521649A (en) * | 2002-01-15 | 2005-07-21 | コグニス・フランス・ソシエテ・アノニム | Active substances for use in cosmetic and / or pharmaceutical products obtained by fermentation of plant components and / or plant extracts |
JP2003238429A (en) * | 2002-02-12 | 2003-08-27 | Kyoei Kagaku Kogyo Kk | Fibroblast cell-activating agent and skin external agent containing the same |
JP2004010526A (en) * | 2002-06-06 | 2004-01-15 | Kose Corp | Skin care preparation for external use |
JP2005008539A (en) * | 2003-06-17 | 2005-01-13 | Fancl Corp | Matrix metalloproteinase inhibitor |
JP2005015450A (en) * | 2003-06-30 | 2005-01-20 | Kanebo Cosmetics Inc | Skin cosmetic |
JP2005047860A (en) * | 2003-07-30 | 2005-02-24 | Intaafueesu:Kk | Beautiful skin enhancer |
JP2005112780A (en) * | 2003-10-07 | 2005-04-28 | Kyoei Kagaku Kogyo Kk | Antioxidant and cosmetic containing the same |
JP2005154375A (en) * | 2003-11-27 | 2005-06-16 | Kyoei Kagaku Kogyo Kk | Skin lotion |
JP2005255613A (en) * | 2004-03-11 | 2005-09-22 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2005298489A (en) * | 2004-03-15 | 2005-10-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2005320308A (en) * | 2004-05-11 | 2005-11-17 | Kyoei Kagaku Kogyo Kk | Enzymic treated hydrolyzate and cosmetic comprising the same formulated therein |
JP2006045075A (en) * | 2004-08-02 | 2006-02-16 | Yukihiro Hirose | Composition having bleaching action and cosmetic containing the same |
JP2006104129A (en) * | 2004-10-06 | 2006-04-20 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2006111560A (en) * | 2004-10-14 | 2006-04-27 | Nippon Menaade Keshohin Kk | Ceramide synthesis promoter |
JP2006124350A (en) * | 2004-11-01 | 2006-05-18 | Nippon Menaade Keshohin Kk | Nmf production promoter |
JP2006296255A (en) * | 2005-04-19 | 2006-11-02 | Maruzen Pharmaceut Co Ltd | Enzymatic decomposition product of cereal, method for producing the same and functional article |
JP2007131578A (en) * | 2005-11-10 | 2007-05-31 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2007290998A (en) * | 2006-04-24 | 2007-11-08 | Morishita Jintan Kk | Sprouted adlay fermentation-treated product |
JP2008081491A (en) * | 2006-09-01 | 2008-04-10 | Kao Corp | External preparation for skin |
JP2010013414A (en) * | 2008-07-07 | 2010-01-21 | Toyo Shinyaku Co Ltd | Melanin formation suppressing agent |
JP2010138139A (en) * | 2008-12-15 | 2010-06-24 | Kyoei Kagaku Kogyo Kk | Skin-lightening agent and skin-lightening cosmetic |
JP2012056933A (en) * | 2010-09-13 | 2012-03-22 | Maruzen Pharmaceut Co Ltd | Elastin production promoter |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014144920A (en) * | 2013-01-25 | 2014-08-14 | Tekunooburu:Kk | External composition for skin |
JP2020090544A (en) * | 2016-05-10 | 2020-06-11 | 丸善製薬株式会社 | Cosmetics and food and drink composition |
JP7460998B2 (en) | 2017-05-18 | 2024-04-03 | 共栄化学工業株式会社 | Skin preparations |
JP7330489B2 (en) | 2019-05-14 | 2023-08-22 | 共栄化学工業株式会社 | Skin topical agent |
JP2021004214A (en) * | 2019-06-27 | 2021-01-14 | 株式会社再春館製薬所 | Combinational fermented product |
Also Published As
Publication number | Publication date |
---|---|
JP6474186B2 (en) | 2019-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4563225B2 (en) | Cosmetics | |
JP5129440B2 (en) | Fermented plant and cosmetics containing the same | |
JP4734093B2 (en) | Cosmetics | |
JP4693623B2 (en) | Cosmetics | |
JP2018193341A (en) | Plant fermentation product | |
JP7248875B2 (en) | Skin topical composition | |
JP6928429B2 (en) | Topical skin agent | |
JP6927660B2 (en) | Topical skin composition and oral composition | |
JP5147805B2 (en) | Cosmetics | |
JP4927337B2 (en) | Cosmetics | |
JP7418853B2 (en) | Skin external preparations | |
JP6474186B2 (en) | Cosmetics | |
JP6462200B2 (en) | Skin external composition | |
JP5780706B2 (en) | Whitening cosmetics | |
JP4488861B2 (en) | Cosmetics | |
JP2012087091A (en) | Cosmetic | |
JP5483928B2 (en) | Cosmetics | |
JP2017105745A (en) | Skin external preparation | |
JP2011032186A (en) | Cosmetic | |
JP2018193336A (en) | Skin external preparation | |
JP6951908B2 (en) | Topical skin agent | |
JP2010138139A (en) | Skin-lightening agent and skin-lightening cosmetic | |
JP2021172593A (en) | External preparation for skin | |
JP7349116B2 (en) | External skin preparations and food and drink products | |
JP7460998B2 (en) | Skin preparations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20151125 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160905 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161004 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161202 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170328 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170529 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20170801 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181011 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190129 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6474186 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |